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ABOUT A REVOLUTION: TOWARD 
INTEGRATED TREATMENT IN DRUG AND 
MENTAL HEALTH COURTS* 
SARA GORDON** 
This Article examines specialty courts, including drug, alcohol, 
and mental health courts, which proponents claim created a 
revolution in criminal justice. Defendants whose underlying 
crime is the result of a substance use disorder or a mental health 
disorder can choose to be diverted into a specialty court, where 
they receive treatment instead of punishment. Many of these 
individuals, however, do not just suffer from a substance use 
disorder or a mental health disorder; instead, many have a “co-
occurring disorder.” Approximately 8.9 million American adults 
have co-occurring mental health and substance use disorders, 
and almost half of individuals who meet diagnostic criteria for 
one disorder will also meet criteria for the other. Moreover, an 
extensive body of literature has shown that treatment for co-
occurring disorders should be integrated and that individuals 
should receive appropriate mental health and substance abuse 
treatment from a single clinician or clinical team. 
This Article argues that the segregation of drug, alcohol, and 
mental health courts is out of step with our current understanding 
of the high rates of co-occurring disorders, and often fails to 
provide integrated treatment for the multiple disorders a single 
specialty-court participant might present. Moreover, by 
segregating specialty courts, we are further stigmatizing addiction 
and failing to acknowledge that drug and alcohol use disorders 
are some of the many types of mental illnesses recognized by the 
medical community. Drug, alcohol, and mental health courts 
should therefore move away from their traditional siloed 
approach to the selection and treatment of participants and 
instead provide individuals with comprehensive and integrated 
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treatment for co-occurring substance use and mental health 
disorders. 
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INTRODUCTION 
I didn’t realize I actually had post-traumatic stress disorder at the 
time, but why would I think I had that? Anyway, how would I 
know which was post-traumatic stress, which is addiction, which 
is bipolar, which is Libra?1 
Although she is perhaps best known as Princess Leia, the actress 
Carrie Fisher also spoke openly about her history of addiction and 
mental illness and “once joked that she wanted to start a ‘Bipolar 
Pride Day’ to help erase the stigma of the disease.”2 When she died in 
December 2016 after suffering a heart attack on a flight to Los 
Angeles, many of her fans remembered Fisher not only for her career 
as an actress, author, and screenwriter but also for her nearly life-long 
struggle with what mental health professionals describe as a “co-
 
 1. CARRIE FISHER, WISHFUL DRINKING 143 (2008). 
 2. Ryan Burleson & Tara Parker-Pope, Fans Tweet About Mental Illness to Honor 
Carrie Fisher, N.Y. TIMES (Dec. 27, 2016), https://www.nytimes.com/2016/12/27/arts/carrie-
fisher-bipolar-disorder.html [https://perma.cc/ZM38-K4BG (dark archive)]. At the 
beginning of her memoir, Fisher notes that if her life were not funny, “it would just be 
true, and that is unacceptable.” FISHER, supra note 1, at 17. She describes “Bipolar Pride 
Day” this way: “You know, with floats and parades and stuff! On the floats we would get 
the depressives, and they wouldn’t even have to leave their beds. .	.	. And then for the 
manics, we’d have the manic marching band. .	.	.” Id. at 127. 
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occurring disorder,” or a diagnosis of at least one mental health 
condition and one substance use disorder.3 
As Fisher described it: “I used to think I was a drug addict, pure 
and simple—just someone who could not stop taking drugs willfully. 
.	.	. And I was that. But it turns out that I am severely manic 
depressive.”4 Fisher started using drugs around the age of thirteen,5 
continued taking drugs like LSD and Percodan during the 1970s and 
1980s,6 and admitted to a reporter that she “did cocaine on the set of 
[The] Empire [Strikes Back], in the ice planet .	.	.	.”7 In 1985, after 
filming a role in the Woody Allen film Hannah and Her Sisters, she 
nearly overdosed and entered an inpatient rehabilitation facility in 
Los Angeles.8 When she died in 2016, an autopsy found cocaine, 
methadone, heroin, and MDMA in her system.9 In addition to illegal 
substances, Fisher was taking Lamictal, a commonly prescribed 
bipolar medication, along with the antidepressants Prozac and 
 
 3. Burleson & Parker-Pope, supra note 2 (“Legions of fans seemed to grant her wish 
on Tuesday in the hours after her death at age 60. One after another, in words both plain-
spoken and deeply personal, admirers paid tribute to Ms. Fisher by ‘coming out’ on 
Twitter with their own stories of mental illness.”); see also U.S. DEP’T OF HEALTH & 
HUM. SERVS., SUBSTANCE ABUSE TREATMENT FOR PERSONS WITH CO-OCCURRING 
DISORDERS: A TREATMENT IMPROVEMENT PROTOCOL TIP 42, at 3 (2013) [hereinafter 
TIP], https://store.samhsa.gov/file/23170/download?token=FBHtrcSs [https://perma.cc/W5FU-
ZCPP (staff-uploaded archive)] (“Clients said to have co-occurring disorders have one or 
more disorders relating to the use of alcohol and/or other drugs of abuse as well as one or 
more mental disorders.”); Mary Ann Priester et al., Treatment Access Barriers and 
Disparities Among Individuals with Co-Occurring Mental Health and Substance Use 
Disorders: An Integrative Literature Review, 61 J. SUBSTANCE ABUSE TREATMENT 47, 47 
(2016) (“[A] diagnosis of [a co-occurring disorder] requires that at least one mental illness 
and one substance use disorder (SUD) must be able to be diagnosed independently.”). 
 4. PrimeTime: Carrie Fisher Interview, ABC NEWS (Dec. 21, 2000), 
https://abcnews.go.com/Primetime/story?id=132315&page=1 [https://perma.cc/Q8N2-FY32].  
 5. FISHER, supra note 1, at 131. 
 6. Dave Itzkoff, Carrie Fisher, Child of Hollywood and ‘Star Wars’ Royalty, Dies at 
60, N.Y. TIMES (Dec. 27, 2016), https://www.nytimes.com/2016/12/27/movies/carrie-fisher-
dead-star-wars-princess-leia.html [https://perma.cc/7LRL-7ASA (dark archive)]. 
 7. Ben Child, Carrie Fisher Admits Taking Cocaine on Set of The Empire Strikes 
Back, GUARDIAN (Oct. 12, 2010), https://www.theguardian.com/film/2010/oct/12/carrie-
fisher-cocaine-star-wars [https://perma.cc/YMF6-DE3Y]. 
 8. Itzkoff, supra note 6.  
 9. Gene Maddaus, Carrie Fisher Had Cocaine, Heroin, Ecstasy in Her System, 
Autopsy Shows, VARIETY (June 19, 2017, 9:15 AM), https://variety.com/2017/biz/news/
carrie-fisher-autopsy-cocaine-heroin-ecstasy-1202470282/ [https://perma.cc/G7CN-K23A] 
(“The coroner’s report listed sleep apnea as the primary cause of death, with drug intake 
as a contributing factor. .	.	. Fisher died on Dec. 27, four days after going into cardiac arrest 
on an airplane arriving at LAX from London. The report states that Fisher’s assistant was 
on the plane with her. The assistant reported that she was awake and normal at the 
beginning of the flight, but had ‘multiple apneic episodes, which was her baseline’ during 
the flight. At the end of the flight, she could not be awoken.”). 
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Abilify.10 In her memoir, Fisher described her bipolar states by name: 
Rollicking Roy, “the wild ride of a mood,” and Sediment Pam, “who 
stands on the shore and sobs.”11 
Although Fisher is a well-known example of a person with both a 
substance use disorder and a mental health disorder, this type of 
diagnosis is not uncommon. Like Fisher, when an individual meets 
clinical criteria for both a substance use disorder and a mental health 
disorder, that person is said to have a co-occurring disorder, or a 
“dual-diagnosis.”12 Approximately 8.9 million American adults have 
co-occurring mental health and substance use disorders,13 and “the 
services of the mental health and substance abuse treatment systems 
will be needed by a substantial number of Americans at one time or 
another in their lifetime.”14 Rates of co-occurring disorders are high 
because addiction often occurs concurrently with or contributes to 
many different medical conditions, including physical conditions like 
heart disease,15 as well as mental health and behavioral disorders like 
depression and anxiety.16 In fact, a major risk factor for addiction is 
the presence of mental illness.17 
Addiction and mental illness also share a painful history in which 
people with one or both diagnoses “endured institutions that offered 
no treatment, ineffective treatment, or well-intentioned treatment 
that did harm.”18 Because of historical stigmatization, some 
individuals with substance use disorders, mental health disorders, or 
 
 10. Id. 
 11. FISHER, supra note 1, at 121 (“One mood is the meal and the next mood is the 
check.”). 
 12. Priester et al., supra note 3, at 47; see also TIP, supra note 3, at 3. 
 13. Priester et al., supra note 3, at 47. 
 14. Stanley Sacks, Redonna Chandler & Junius Gonzales, Responding to the 
Challenge of Co-Occurring Disorders: Suggestions for Future Research, 34 J. SUBSTANCE 
ABUSE TREATMENT 139, 140 (2008). 
 15. See Mental Health and Heart Health, AM. HEART ASS’N (Apr. 18, 2018), 
https://www.heart.org/en/healthy-living/healthy-lifestyle/mental-health-and-wellbeing/mental-
health-and-heart-health [https://perma.cc/5KD7-8M4H]. 
 16. See Kathleen T. Brady & Rajita Sinha, Co-Occurring Mental and Substance Use 
Disorders: The Neurobiological Effects of Chronic Stress, 162 AM. J. PSYCHIATRY 1483, 
1483 (2005) (“The high rate of co-occurrence of substance use disorders and other 
psychiatric disorders is well established.”). 
 17. M. Tyler Boden & Rudolf Moos, Dually Diagnosed Patients’ Responses to 
Substance Use Disorder Treatment, 37 J. SUBSTANCE ABUSE TREATMENT 335, 335 (2009) 
(“The prevalence of psychiatric disorders among individuals with substance use disorders 
(SUDs) is quite high, with estimates ranging from 18% to 70% among those seeking 
treatment for SUDs.”). 
 18. Larry Davidson & William White, The Concept of Recovery as an Organizing 
Principle for Integrating Mental Health and Addiction Services, 34 J. BEHAV. HEALTH 
SERVS. & RES. 109, 110 (2007). 
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some combination of the two first receive treatment as a result of 
their involvement with the criminal justice system. A recent study by 
the Department of Justice assessed over one million state prison, 
federal prison, and local jail inmates for mental health problems and 
found that 55% of all inmates had “a recent history or symptoms of a 
mental health problem” that had occurred in the previous twelve 
months.19 Moreover, among inmates with a mental health problem, 
between 64% and 76% had a co-occurring substance use disorder.20 
Those with mental health problems were also more likely to abuse 
illegal drugs and alcohol and to have a family history of substance 
abuse.21 
While all federal penitentiaries and most state prisons and jails 
do provide some mental health services to inmates,22 many other 
individuals first enter into treatment after they have been arrested 
and diverted to a specialty court. The first specialty courts were drug 
courts, which were created to provide treatment and services to 
individuals whose involvement with the criminal justice system was 
likely due to an underlying addiction.23 The first drug court was 
established in Florida in 1989, and today there are over 2500 drug 
courts across every state in the country.24 As the drug court model 
grew in popularity, states began establishing other specialty courts, 
 
 19. DORIS J. JAMES & LAUREN E. GLAZE, MENTAL HEALTH PROBLEMS OF PRISON 
AND JAIL INMATES 1 (Tina Dorsey et al. eds., 2006) (“At midyear 2005 more than half of 
all prison and jail inmates had a mental health problem, including 705,600 inmates in State 
prisons, 78,800 in Federal prisons, and 479,900 in local jails. These estimates represented 
56% of State prisoners, 45% of federal prisoners, and 64% of jail inmates. The findings in 
this report were based on data from personal interviews with State and Federal prisoners 
in 2004 and local jail inmates in 2002.”). 
 20. Id. at 6 (“Among inmates who had a mental health problem, local jail inmates had 
the highest rate of dependence or abuse of alcohol or drugs (76%), followed by State 
prisoners (74%), and Federal prisoners (64%) .	.	.	. Substance dependence or abuse was 
measured as defined in the DSM-IV. Among inmates without a mental health problem, 
56% in State prisons, 49% in Federal prisons, and 53% in local jails were dependent on or 
abused alcohol or drugs.”). 
 21. Id. at 6 tbl.6. 
 22. Id. at 9 (“State prisoners who had a mental health problem (34%) had the highest 
rate of mental health treatment since admission, followed by federal prisoners (24%) and 
local jail inmates (17%).”). 
 23. RYAN S. KING & JILL PASQUARELLA, THE SENTENCING PROJECT, DRUG 
COURTS: A REVIEW OF THE EVIDENCE 1 (2009), http://www.sentencingproject.org/wp-
content/uploads/2016/01/Drug-Courts-A-Review-of-the-Evidence.pdf [https://perma.cc/H45F-
K2P2]. 
 24. Id.; see also JUSTICE POLICY INST., ADDICTED TO COURTS: HOW A GROWING 
DEPENDENCE ON DRUG COURTS IMPACTS PEOPLE AND COMMUNITIES 18–20 (2011), 
http://www.justicepolicy.org/uploads/justicepolicy/documents/addicted_to_courts_final.pdf 
[https://perma.cc/5AV2-SV37]. 
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including mental health courts,25 as well as alcohol and driving while 
intoxicated (“DWI”) courts.26 
These specialty courts offer would-be defendants “the choice of 
participating in an intensive court-monitored treatment program as 
an alternative to the normal adjudication process.”27 As this Article 
will explore, however, not all specialty courts are created equal. 
Unlike drug and alcohol courts, which focus on drug- and alcohol-
related charges and often have a more punitive focus,28 mental health 
courts are often described as “treatment courts” and have the stated 
goal of connecting participants to available community resources.29 
Furthermore, this segregated specialty court model is out of step with 
our current understanding of both the nature of the disease of 
addiction, as well as the existence of high rates of co-occurring 
disorders. As a result, these segregated courts perpetuate the stigma 
surrounding addiction by categorizing individuals with a substance 
use disorder differently than individuals with a broader mental health 
disorder. Moreover, both drug and mental health courts often fail to 
provide appropriate treatment for the multiple disorders a single 
 
 25. Other specialty courts include tribal courts, reentry courts, DWI courts, juvenile 
drug courts, domestic violence courts, truancy courts, prostitution courts, and 
homelessness courts, among others. JUSTICE POLICY INST., supra note 24, at 18–20; see 
also WEST HUDDLESTON & DOUGLAS B. MARLOWE, U.S. DEP’T OF JUSTICE, PAINTING 
THE CURRENT PICTURE: A NATIONAL REPORT ON DRUG COURTS AND OTHER 
PROBLEM-SOLVING COURT PROGRAMS IN THE UNITED STATES 68 (2011), 
http://www.ndci.org/sites/default/files/nadcp/PCP%20Report%20FINAL.PDF [https://perma.cc/
WH65-WD7Y] (“The extraordinary success of Adult Drug Courts has produced a wide 
variety of other types of Drug Court programs.”). 
 26. SUZANNE M. STRONG, RAMONA R. RANTALA & TRACEY KYCKELLHAHN, U.S. 
DEP’T OF JUSTICE, CENSUS OF PROBLEM-SOLVING COURTS, 2012, at 1 (2016), 
https://www.bjs.gov/content/pub/pdf/cpsc12.pdf [https://perma.cc/5EZ3-GDUW]. 
 27. JAMES L. NOLAN, JR., REINVENTING JUSTICE: THE AMERICAN DRUG COURT 
MOVEMENT 5 (2001). 
 28. Patricia A. Griffin, Henry J. Steadman & John Petrila, The Use of Criminal 
Charges and Sanctions in Mental Health Courts, 53 PSYCHIATRIC SERVS. 1285, 1288 
(2002) (“The use of punishment is considered a core feature of drug courts and is used 
routinely in that setting.”); see also U.S. DEP’T OF JUSTICE, MENTAL HEALTH COURTS: A 
PRIMER FOR POLICYMAKERS & PRACTITIONERS 9 (2008), https://csgjusticecenter.org/wp-
content/uploads/2012/12/mhc-primer.pdf [https://perma.cc/VH7M-33UG] (noting the 
difference between drug courts and mental health courts). 
 29. LAUREN ALMQUIST & ELIZABETH DODD, COUNCIL OF STATE GOV’TS JUSTICE 
CTR., MENTAL HEALTH COURTS: A GUIDE TO RESEARCH-INFORMED POLICY AND 
PRACTICE 2 (2009), https://www.bja.gov/Publications/CSG_MHC_Research.pdf [https://perma.cc/
9FVV-H42F] (citing several studies and observing that “[m]ental health courts have several 
goals: to improve public safety by reducing the recidivism rates of people with mental 
illnesses, to reduce corrections costs by providing alternatives to incarceration, and to 
improve the quality of life of people with mental illnesses by connecting them with 
treatment and preventing re-involvement in the criminal justice system”). 
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individual might present. This Article argues that drug, alcohol, and 
mental health courts should move away from their traditional, siloed 
approach to the selection and treatment of participants and instead 
provide individuals with comprehensive, evidence-based treatment 
for co-occurring substance use and mental health disorders. 
Part I of this Article examines the evolution of the current 
specialty court model, including the historical forces that helped 
create the current siloed approach to treatment. This Part also 
considers some of the obstacles to the provision of integrated 
treatment for co-occurring mental health and substance use disorders. 
Part II discusses contemporary scientific understanding of the disease 
of addiction and its diagnosis. Part III explores the prevalence of co-
occurring disorders, focusing particularly on the rates of co-occurring 
substance use and mental health disorders. Part IV describes current 
best practices for treatment of individuals with co-occurring disorders, 
as well as the significant dearth of training opportunities for 
treatment providers. Finally, Part V examines the role of specialty 
courts in the provision of treatment services for co-occurring mental 
health and substance use disorders. This Part argues that drug, 
alcohol, and mental health courts should be integrated both because 
substance use disorder is a mental illness that should no longer be 
relegated to the fringes of the mental health system and because co-
occurring disorders in specialty court participants should be 
“expected rather than considered an exception.”30 Finally, this Part 
highlights the need for specialty court judges, staff, and policymakers 
to become better educated about advances in the research and 
treatment of co-occurring disorders because our greater 
understanding of co-occurring disorders “will be useful only if there is 
a treatment system in place to implement these findings.”31 
I.  ABOUT A REVOLUTION: SPECIALTY COURTS AND THE CRIMINAL 
JUSTICE SYSTEM 
The Miami-Dade Drug Court sparked a national revolution that 
has forever changed our justice system.32 
 
 30. Kenneth Minkoff, Developing Standards of Care for Individuals with Co-
Occurring Psychiatric and Substance Use Disorders, 52 PSYCHIATRIC SERVS. 597, 597 
(2001). 
 31. Brady & Sinha, supra note 16, at 1490 (“[C]hange at public policy levels will be 
necessary to maximize the benefits derived from the findings of neurobiological 
explorations in order to improve the lives of individuals with comorbidity.”). 
 32. History, NAT’L CTR. FOR DWI CTS., https://www.dwicourts.org/uncategorized/
drug-court-history/ [https://perma.cc/9U7N-JRC3]. 
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The first drug court was established in Miami-Dade County, 
Florida, in 1989.33 This special court was originally conceived as a way 
to divert individuals with drug addiction out of the criminal justice 
system and address the underlying addiction that led to the 
individual’s arrest.34 Drug courts draw on therapeutic goals and seek 
to provide addiction treatment to individuals whose involvement with 
the criminal justice system is likely due to an underlying addiction.35 
Drug courts offer criminal defendants with substance use disorders 
the option of receiving court-monitored treatment, where the court 
itself directs and guides the treatment process.36 In addition to these 
therapeutic goals, however, drug courts also evolved as a more 
practical response to the huge number of criminal cases on court 
calendars, where many defendants with substance use disorders 
“swamped the unprepared criminal justice system.”37 
Drug and other specialty courts have been widely praised as 
“revolutionary” and “innovative.”38 Indeed, “[t]he idea that the drug 
court is an innovative form of justice is repeated like a mantra by its 
supporters.”39 Moreover, as one Louisville drug court judge observed, 
 
 33. KING & PASQUARELLA, supra note 23, at 1; see also NOLAN, supra note 27, at 5 
(“The burgeoning drug court movement first developed in response to the growing 
number of drug cases overcrowding America’s criminal court calendars.”).  
 34. STRONG ET AL., supra note 26, at 1. 
 35. KING & PASQUARELLA, supra note 23, at 1; see also Michelle Edgely, Why Do 
Mental Health Courts Work? A Confluence of Treatment, Support & Adroit Judicial 
Supervision, 37 INT’L J.L. & PSYCHIATRY 572, 572 (2014) (describing mental health 
courts, which grew out of the original drug court model, as “us[ing] a therapeutic 
jurisprudence orientation to seek to reduce recidivism”); Michael L. Perlin, “The Judge, 
He Cast His Robe Aside”: Mental Health Courts, Dignity and Due Process, 3 MENTAL 
HEALTH L. & POL’Y J. 1, 2–3 (2013) (describing mental health courts as “significant 
because of their articulated focus on dignity, as well as their embrace of therapeutic 
jurisprudence, their focus on procedural justice, and their use of the principles of 
restorative justice”). 
 36. NOLAN, supra note 27, at 39–40. 
 37. JANINE M. ZWEIG ET AL., URBAN INST. JUSTICE POLICY CTR., 2 THE MULTI-
SITE ADULT DRUG COURT EVALUATION 7 (Shelli B Rossman et al. eds., 2011) (citing 
various studies). The report details a number of reasons for the increase in criminal drug 
charges, including “drug use prevalence, the crack cocaine epidemic of the 1980s, and 
changes in legislation and criminal codes.” Id. These factors resulted in a “nearly three-
fold increase in drug and drug-related arrests” during the last quarter of the twentieth 
century. Id.; see also Peggy Fulton Hora, William G. Schma & John T.A. Rosenthal, 
Therapeutic Jurisprudence and the Drug Treatment Court Movement: Revolutionizing the 
Criminal Justice System’s Response to Drug Abuse and Crime in America, 74 NOTRE 
DAME L. REV. 439, 449 (1999) (noting that the focus of the first drug courts was “aimed 
squarely at preventing the collapse of local court systems under the weight of drug cases”). 
 38. NOLAN, supra note 27, at 5 (“Judges celebrate the drug court as an exciting 
movement, a new way of justice, even a revolution in American jurisprudence.”). 
 39. Eric J. Miller, Embracing Addiction: Drug Courts and the False Promise of 
Judicial Interventionism, 65 OHIO ST. L.J. 1479, 1503 n.137 (2004); see also Hora et al., 
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the drug court model is “totally a grassroots kind of thing.”40 These 
courts typically developed as a way to address a jurisdiction’s 
particular needs at a local level.41 The courts are often created by 
individual judges who then work to gain public support, gathering at 
national conferences to “strategize about the ways they can get 
outsiders to accept and support the drug court program.”42 This is not 
entirely surprising, given that judges are on the ground—witnesses to 
the institutional realities of enormous criminal calendars, 
overcrowded prisons, and huge recidivism rates—and need to come 
up with some other method for dealing with the large number of 
criminal defendants charged with drug crimes.43 As one author put it, 
“[t]he first [drug] courts were the product of local innovation and 
‘elbow grease[]’ .	.	.	.”44 
While the praise has not been unanimous,45 the drug court model 
has proved popular and received generally positive news coverage 
and public support.46 Inspired by the success of the original drug court 
model, judges began creating other specialty courts, including mental 
health courts, family courts, youth specialty courts, DWI courts, 
domestic violence courts, veterans courts, tribal wellness courts, and 
 
supra note 37, at 440 (describing the “existence, breadth, and importance of the [drug 
court] movement in this country”). 
 40. NOLAN, supra note 27, at 42 (quoting Louisville Drug Court Judge Henry Weber, 
who notes that while drug courts do receive federal dollars, the movement itself is “not 
something where the bureaucrats in Washington tell you what to do”). 
 41. Id. 
 42. Id. at 42–43 (“The Drug Court movement is essentially a judge-led movement.”); 
see also MITCHELL B. MACKINEM & PAUL HIGGINS, DRUG COURT: CONSTRUCTING THE 
MORAL IDENTITY OF DRUG OFFENDERS 61 (2008) (“[J]udges often lead the effort for 
the establishment of drug court.”). 
 43. NOLAN, supra note 27, at 44 (noting that “the criminal justice system was faced 
with a situation where something new had to be tried” and citing a common refrain from 
drug court officials that “what we were doing before simply was not working”). 
 44. John S. Goldkamp, The Drug Court Response: Issues and Implications for Justice 
Change, 63 ALB. L. REV. 923, 948 (2000). 
 45. For an excellent overview of some of the common objections to the drug court 
model, see generally JUSTICE POLICY INST., supra note 24; Sara Gordon, The Use and 
Abuse of Mutual-Support Programs in Drug Courts, 2017 ILL. L. REV. 1503, 1541 (2017) 
(“Even when individuals are required by courts to receive treatment, much of the 
treatment they receive is not evidence-based and is not delivered in licensed facilities by 
qualified providers.”); Morris B. Hoffman, The Drug Court Scandal, 78 N.C. L. REV. 1437, 
1477 (2000) (“By simultaneously treating drug use as a crime and as a disease, without 
coming to grips with the inherent contradictions of those two approaches, drug courts are 
not satisfying either the legitimate and compassionate interests of the treatment 
community or the legitimate and rational interests of the law enforcement community.”). 
 46. NOLAN, supra note 27, at 5 (noting that problem-solving courts received “almost 
uniformly positive media coverage and overwhelming public support at both the national 
and local levels”). 
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many others.47 The Bureau of Justice Statistics’s most recent census of 
specialty courts counted 3052 specialty courts in the United States.48 
Other researchers suggest the number of drug and other specialty 
courts is even higher, estimating that there are over 2400 drug 
treatment courts and more than 1000 additional specialty courts in the 
United States, the majority of which use the same drug court model.49 
 
 47. Edgely, supra note 35, at 572; see also JUSTICE POLICY INST., supra note 24, at 18–
20; STRONG ET AL., supra note 26, at 1. Other specialty courts include gambling court, 
prostitution court, campus court, and many others. JUSTICE POLICY INST., supra note 24, 
at 18–20.  
Due to the popularity of drug courts, many states and localities have expanded on 
this model to address other social issues experienced by people involved in the 
justice system. .	.	. Here are some of the current specialty courts in place around 
the country[:] 
Tribal Healing and Wellness Court 
A component of the tribal justice system, the Tribal Healing and Wellness 
Courts were created to address alcohol and drug misuse in tribal 
communities. It is based on the traditional drug court model, but is tailored to 
the unique needs of the tribal community and incorporate[s] culture and 
tradition. .	.	. 
Reentry Court 
Started in 2000 by the Office of Justice Programs’ Reentry Court Initiative, 
reentry drug courts were created to aid the unique process of moving from 
prison into the community. .	.	. 
Juvenile Drugs Court 
The juvenile drug court is a special docket within a juvenile court that is 
assigned to a designated judge and involves intensive treatment and 
supervision services for youth with delinquency or status offenses who are 
considered drug-involved. .	.	. 
Community Court 
The community courts deal with quality of life crimes within a community, 
such as prostitution, vandalism, or petty theft. .	.	. 
Gambling Court 
Gambling court operates through existing drug courts, selecting specific cases 
involving people who have a pending criminal charge and suffer from 
pathological or compulsive gambling disorders that may have resulted in 
illegal activity. .	.	. 
Truancy Court 
Truancy courts are designed to identify and assist with the underlying causes 
of truancy occurring in a child’s life. .	.	. 
Id. at 18–19. 
 48. STRONG ET AL., supra note 26, at 1. 
 49. HUDDLESTON & MARLOWE, supra note 25, at 1. According to this report, as of 
December 31, 2009, there were a total of 3648 drug courts and other specialty courts. Id. 
Of these, approximately 2459 were drug courts and the remainder were other specialty 
courts. Id. 
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One recent study found that more than 55,000 people enter drug 
court each year and “about 515 million dollars is spent annually to 
treat those drug court clients.”50 
In the early days of drug courts, messaging was key, as was the 
need for funding. In 1994, a group of “pioneers” from twelve early 
drug courts formed the National Association of Drug Court 
Professionals (“NADCP”), a nonprofit group tasked with creating “a 
common-sense approach to improving the justice system by using a 
combination of judicial monitoring and effective treatment to compel 
drug-using offenders to change their lives.”51 The NADCP is 
committed to persuading legislators, local judges, and the general 
public of these “guiding principles” through legislative lobbying, press 
conferences, and an “ongoing media blitz that landed Drug Courts 
and the NADCP on all major television networks and in Newsweek, 
USA Today, The Washington Post, The New York Times, and 
countless other newspapers.”52 The NADCP has also worked to 
improve the public’s perception of drug and specialty courts and 
recently launched “All Rise,” a public awareness campaign starring 
celebrities, including Matthew Perry, Martin Sheen, and Trey 
Anastasio.53 
According to the NADCP, these efforts have resulted in 
“historical” and “staggering” increases in federal funding for specialty 
 
 50. AVINASH SINGH BHATI, JOHN K. ROMAN & AARON CHALFIN, URBAN INST. 
JUSTICE POLICY CTR., TO TREAT OR NOT TO TREAT: EVIDENCE ON THE PROSPECTS OF 
EXPANDING TREATMENT TO DRUG-INVOLVED OFFENDERS xi–xii (2008), 
https://www.urban.org/sites/default/files/publication/31621/411645-To-Treat-or-Not-to-Treat.	
PDF [https://perma.cc/6DGH-7865]; see also NOLAN, supra note 27, at 43 (noting that the 
drug court model has spread to other countries, including Canada, Australia, and 
England). 
 51. About NADCP, NAT’L CTR. FOR DWI CTS., https://www.dwicourts.org/
uncategorized/about-nadcp/ [https://perma.cc/39KR-KLGV]. 
 52. Id. (“In 2006, NADCP launched a massive campaign to put a Drug Court within 
reach of every American in need. NADCP has aggressively pursued its vision and 
achieved a renewed commitment for Drug Courts among Congress and the general public 
alike.”). 
 53. Nick Gillie & West Huddleston, “All Rise!”: A Better Way of Justice Is Now in 
Session, HUFFPOST (Aug. 21, 2009, 5:12 AM), https://www.huffingtonpost.com/nick-
gillie/all-rise-a-better-way-of_b_242101.html [http://perma.cc/84WH-SDTM]; see also All 
Rise, Martin Sheen: All Rise!, YOUTUBE (Nov. 29, 2011), https://www.youtube.com/
watch?v=YjVQB4EvytI [http://perma.cc/AQ5Z-544L]; All Rise, Matthew Perry Accepts 
the All Rise Ambassador Award for His Dedication to Drug Court Advocacy, YOUTUBE 
(Aug. 3, 2011), https://www.youtube.com/watch?reload=9&v=1SJSblulFqA [http://perma.cc/
242E-XJ8R]; Trey Anastasio Given Award by National Association of Drug Court 
Professionals, HEADCOUNT (Jul. 22, 2011), https://www.headcount.org/trey-anastasio-given-
award-by-national-association-of-drug-court-professionals/ [http://perma.cc/9CP2-PL3A]. 
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courts.54 Whether due to the promotional work of the NADCP or to 
other factors, it is the case that drug and other specialty courts receive 
significant financial support from both the federal government and 
from state and local entities.55 In 1995, the U.S. Department of Justice 
opened the Drug Courts Program Office, which awards grants to 
existing and emerging drug courts.56 Today, however, the majority of 
specialty courts are funded by state grants or through the state 
budget. In 2012, for example, 60% of courts received some funding 
from the state, 23% were funded entirely by the state, and 20% 
received up to half of their funding from court fees or fines.57 
In addition to support from individual states, federal funding for 
specialty courts has remained robust, in part due to the increasing 
recognition of a nationwide opioid epidemic.58 In July 2017, for 
example, the U.S. Department of Health and Human Services 
Substance Abuse and Mental Health Services Administration 
(“SAMHSA”) announced grant funding of up to $80.8 million for 
adult drug courts.59 And in September 2017, Attorney General Jeff 
Sessions announced that the Department of Justice would award 
about $24 million in federal grants to assist state and local 
governments in creating “comprehensive diversion and alternatives to 
incarceration programs for those impacted by the opioid epidemic.”60 
In addition to its fundraising initiatives, the NADCP also 
considers itself responsible for much of the training received by 
specialty court judges and court personnel. As part of these training 
 
 54. About NADCP, supra note 51. 
 55. NOLAN, supra note 27, at 42 (“It’s probably the only movement in the judicial 
system that has bubbled up from the grassroots to the Federal government.”). 
 56. Id. at 41–42 (“In fiscal year 1995 the office granted $12 million in grants to drug 
courts. This increased to $15 million in 1996, to $30 million in both 1997 and 1998, and 
then to $40 million in 1999.”). 
 57. STRONG ET AL., supra note 26, at 12. 
 58. See, e.g., Maya Salam, The Opioid Epidemic: A Crisis Years in the Making, N.Y. 
TIMES (Oct. 26, 2017), https://www.nytimes.com/2017/10/26/us/opioid-crisis-public-health-
emergency.html [https://perma.cc/S268-RE7A (dark-archive)]. 
 59. Announces $80.8 Million in Grants for Adult and Family Treatment Drug Courts, 
and Adult Tribal Healing to Wellness Courts, U.S. DEP’T HEALTH & HUM. SERVS. (July 
14, 2017), https://www.hhs.gov/about/news/2017/07/14/hhs-announces-808-million-grants-
adult-and-family-treatment-drug-courts-and-adult-tribal-healing.html [https://perma.cc/FW28-
BARJ] (“The actual award amounts may vary, depending on the availability of funds.”). 
However, “[f]ewer than a quarter (23%) of these courts operating in 2012 reported that 
they received some federal grants to support their programs.” STRONG ET AL., supra note 
26, at 12. 
 60. Department of Justice Awards Nearly $59 Million to Combat Opioid Epidemic, 
Fund Drug Courts, U.S. DEP’T JUST. (Sept. 22, 2017), https://www.justice.gov/opa/
pr/department-justice-awards-nearly-59-million-combat-opioid-epidemic-fund-drug-courts 
[https://perma.cc/4WUS-WYVL]. 
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efforts, the NADCP created the National Drug Court Institute, “the 
definitive authority on the latest research, best practices, and cutting-
edge innovations to treat offenders facing substance use and mental 
health disorders.”61 According to its website, the NADCP has trained 
over 36,000 drug court judges and court personnel and distributes its 
educational materials to drug courts nationally and internationally.62 
The NADCP also hosts an annual conference on specialty courts and 
criminal justice reform and drew more than 6000 drug court 
personnel to its 2018 conference in Houston, Texas.63 
The NADCP does recognize that large numbers of individuals 
who enter a drug, alcohol, or mental health court meet diagnostic 
criteria for both a substance use and mental health disorder. In 2011, 
it issued a resolution from its Board of Directors concluding that the 
NADCP will “actively collaborate with other organizations to 
advocate expansion of Drug Courts and Mental Health Courts which 
also effectively meet the needs of those participants with co-occurring 
disorders.”64 Notwithstanding this recognition, however, and perhaps 
in part due to its history of individual judges tackling local problems, 
the vast majority of specialty courts are still targeted toward small 
segments of the population, accepting individuals into segregated 
gambling courts, homeless courts, or veterans courts.65 In particular, 
the majority of individuals who enter a specialty court are referred 
into either drug, alcohol, or mental health court.66 
The original drug court model served as a basis for the 
development of alcohol and DWI courts, as well as mental health 
courts.67 But, unlike drug courts, which focus on drug-related charges 
and often have a more punitive focus,68 mental health courts are often 
 
 61. About NDCI, NAT’L DRUG CT. INST., https://www.ndci.org/about-ndci/ 
[https://perma.cc/4Q7Q-7JLK]. 
 62. About NADCP, supra note 51 (noting that it has “developed 37 publications, 
disseminating them to 456,166 professionals worldwide”). 
 63. Chris Deutsch, Conference May Be Over but the Mission Continues, NAT’L ASS’N 
DRUG CT. PROFS., http://www.nadcp.org/nadcp-conference/conference-may-be-over-but-
the-mission-continues/ [https://perma.cc/GRS2-VAY7]. 
 64. NAT’L ASS’N OF DRUG COURT PROF’LS, RESOLUTION OF THE BOARD OF 
DIRECTORS ON IMPROVING OUTCOMES FOR JUSTICE INVOLVED PERSONS WITH 
MENTAL ILLNESSES INCLUDING THOSE WITH CO-OCCURRING SUBSTANCE ABUSE 
DISORDERS 3 (2011), http://ndcrc.org/resource/improving-outocmes-for-justice-involved-
persons-with-mental-illnesses-including-those-with-co-occurring-substance-abuse-disorders/ 
[https://perma.cc/QUB4-2RPD]. 
 65. See supra Part I.  
 66. See infra Part V.  
 67. See JUSTICE POLICY INST., supra note 24, at 18; Edgely, supra note 35, at 572.  
 68. U.S. DEP’T OF JUSTICE, supra note 28, at 9; Griffin et al., supra note 28, at 1288; 
see also Philip Bean, America’s Drug Courts: A New Development in Criminal Justice, 1996 
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described as treatment courts and have the stated goal of connecting 
participants to available community resources.69 As one author noted, 
“punishment is considered a core feature of drug courts and is used 
routinely in that setting,” while there is more reluctance to impose 
punishment “if the perceived cause of the criminal behavior is mental 
illness.”70 Mental health courts, therefore, have a different focus than 
drug courts, and have been described as “not merely drug courts for 
people with mental illnesses.”71 
When individuals are arrested for a drug-related charge, they are 
often diverted into a drug court.72 In contrast, mental health courts 
admit defendants charged with a variety of offenses.73 Significantly, 
drug courts and mental health courts are often distinguished from one 
another due to the fact that “mental illness, unlike drug use, is, in and 
of itself, not a crime .	.	.	.”74 Moreover, unlike drug courts, which 
typically limit participants to nonviolent drug crimes,75 many mental 
health courts are willing to accept participants who are charged with 
more serious felony offenses or violent crimes, in part because the 
longer sentences available for participants charged with felonies allow 
the court to coordinate and supervise community-based treatment for 
longer periods of time.76 
 
CRIM. L. REV. 718, 719 (“[T]he control exercised by Drug Courts means offenders can no 
longer manipulate the system as they have done hitherto. With up-to-date urinalysis, and 
daily reports from treatment providers, control is firm and obvious.”). 
 69. ALMQUIST & DODD, supra note 29, at 2 (describing a variety of goals for mental 
health courts, including goals “to improve public safety by reducing the recidivism rates of 
people with mental illnesses, to reduce corrections costs by providing alternatives to 
incarceration, and to improve the quality of life of people with mental illnesses by 
connecting them with treatment and preventing re-involvement in the criminal justice 
system”). 
 70. Griffin et al., supra note 28, at 1288. 
 71. U.S. DEP’T OF JUSTICE, supra note 28, at 9; John Petrila et al., Preliminary 
Observations from an Evaluation of the Broward County Mental Health Court, CT. REV., 
Winter 2001, at 14, 20 (noting that the difference between drug courts and mental health 
courts “is a fundamental one”). 
 72. Similarly, individuals arrested for an alcohol-related offense, like a DWI charge, 
are referred to an alcohol or DWI court, where the focus is “on changing the behavior of 
the alcohol-dependent offender .	.	.	.” STRONG ET AL., supra note 26, at 2; see also infra 
text accompanying note 209.  
 73. U.S. DEP’T OF JUSTICE, supra note 28, at 9. 
 74. Id. 
 75. Few drug courts will accept a defendant who is charged with a violent crime, 
including felony domestic violence (20.1%) or misdemeanor violence (16.3%). ZWEIG ET 
AL., supra note 37, at 25–26, 26 tbl.2-2.5. Many courts explicitly exclude individuals 
charged with crimes against other people or against children. See id. 
 76. ALMQUIST & DODD, supra note 29, at 9 (“[S]ome jurisdictions decided to focus 
on people with felony charges to allow court professionals to engage participants in 
community-based treatment for longer periods of time, which was perceived as necessary 
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Yet high rates of co-occurring mental illness and substance use 
disorders “also suggests significant overlap in the target populations 
of these related court programs.”77 In fact, some jurisdictions initially 
established mental health courts because existing drug courts did not 
have the resources to manage participants with serious mental 
illnesses.78 Additionally, numerous studies have confirmed that rates 
of co-occurring disorders among mental health court participants are 
similar to those seen among the general population.79 For example, 
83% of participants in a Santa Barbara, California, mental health 
court had a co-occurring substance use diagnosis, while 59% of 
participants in the Anchorage, Alaska, mental health court and 56% 
of participants in the San Francisco, California, mental health court 
had a similar diagnosis.80 
This piecemeal approach where individuals with drug or alcohol 
related charges are assigned to drug court and other individuals are 
assigned to mental health court is contrary to the literature on co-
occurring disorders, which indicates that co-occurring mental health 
and substance use disorders occur so frequently that they “should be 
expected rather than considered an exception.”81 If specialty courts 
are to continue providing “cutting-edge innovations to treat offenders 
facing substance use and mental health disorders,”82 the structure of 
the specialty court system should itself be changed to provide 
comprehensive and integrated treatment to participants. Unless 
specialty courts are restructured to eliminate the artificial barriers 
between drug, alcohol, and mental health courts, it seems unlikely 
that individual courts will be able to adequately address the huge 
 
to produce positive outcomes. The longer stays for individuals charged with serious crimes 
was not longer than the prison sentences they would have faced if convicted.”). But see E. 
Lea Johnston & Conor P. Flynn, Mental Health Courts and Sentencing Disparities, 62 
VILL. L. REV. 685, 693 (2017) (finding that mental health court sentences in an Erie 
County, Pennsylvania, court “typically exceed county court sentences by more than a 
year”); Ira Glass, Very Tough Love, THIS AM. LIFE (Mar. 25, 2011), 
http://www.thisamericanlife.org/radio-archives/episode/430/very-tough-loveo [https://perma.cc/
Z5JX-D3DH] (describing the story of Lindsey Dills, a seventeen-year-old girl who forged 
two checks from her parents’ bank account, “one for $40 and one for $60,” and was a 
participant in drug court for almost six years. This time period included “14 months 
behind bars, and then .	.	. another five years after that—six months of it in Arrendale State 
Prison, the other four and a half on probation”). 
 77. U.S. DEP’T OF JUSTICE, supra note 28, at 9. 
 78. Id. 
 79. See infra Part III. 
 80. ALMQUIST & DODD, supra note 29, at 10. 
 81. Minkoff, supra note 30, at 597. 
 82. About NDCI, supra note 61. 
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number of individuals with co-occurring disorders who are diverted 
out of the criminal justice system and into specialty courts. 
Moreover, and as discussed in the next part, substance use 
disorder is a brain disease, which is recognized and diagnosed like any 
other mental illness. The segregation of drug, alcohol, and mental 
health courts is yet another barrier to the widespread acceptance of 
addiction as a disease, one that should be evaluated and treated like 
any other mental health disorder, and not relegated to the fringes of 
mainstream medicine. 
II.  SUBSTANCE USE DISORDER: A MENTAL ILLNESS ON THE 
FRINGES 
Substance use disorder—or addiction83—is a complex brain 
disease that affects multiple parts of the brain, “including those 
involved in reward and motivation, learning and memory, and 
inhibitory control over behavior.”84 The disease of addiction affects 
nearly 16% of Americans over the age of twelve—over forty million 
people—more than the number of people with heart disease, 
diabetes, or cancer.85 An additional 31.7%, or 80.4 million people, 
“engages in risky use of addictive substances in ways that threaten 
[their] health and safety,” or the safety of others.86 Addiction is also a 
chronic disorder, one that requires ongoing treatment and 
management.87 
 
 83. Although the DSM-5 has eliminated the word “addiction,” many clinicians and 
researchers continue to use the term, and this Article will use both “addiction” and 
“substance use disorder” to encompass “substance use disorder” as it is defined in the 
DSM-5. AM. PSYCHIATRIC ASS’N, DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL 
DISORDERS 483 (5th ed. 2013) [hereinafter DSM-5]. 
 84. Nora D. Volkow, Preface to the Third Edition of NAT’L INST. ON DRUG ABUSE, 
PRINCIPLES OF DRUG ADDICTION TREATMENT: A RESEARCH BASED GUIDE 3, 3 (3d ed. 
2018), https://d14rmgtrwzf5a.cloudfront.net/sites/default/files/675-principles-of-drug-addiction-
treatment-a-research-based-guide-third-edition.pdf [https://perma.cc/44T4-5QEY]; Charles 
Dackis & Charles O’Brien, Neurobiology of Addiction: Treatment and Public Policy 
Ramifications, 8 NATURE NEUROSCIENCE 1431, 1431 (2005) (noting that, in the United 
States, the “public .	.	. views addiction more as a social problem than an actual disease, 
despite scientific evidence supporting a disease concept of addiction based on neuronal 
mechanisms, heritability, treatment responses and a characteristic progressive clinical 
course”). 
 85. Drew E. Altman, Preface to NAT’L CTR. ON ADDICTION & SUBSTANCE ABUSE 
AT COLUMBIA UNIV., ADDICTION MEDICINE, CLOSING THE GAP BETWEEN SCIENCE 
AND PRACTICE, at i, i (2012) https://www.centeronaddiction.org/download/file/fid/1177 
[https://perma.cc/R5Z5-4E4H] (“Addiction affects 16 percent of Americans ages 12 and 
older—40 million people. That is more than the number of people with heart disease (27 
million), diabetes (26 million) or cancer (19 million).”). 
 86. Id. at 1. 
 87. Id. at 7. 
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The field of addiction research has grown significantly over the 
last several decades, beginning with animal models and expanding to 
include neuroimaging studies of the brains of individuals with 
addiction.88 The literature on addiction has consistently demonstrated 
a biological basis for the disease and has established that addiction is 
a disease that affects the reward centers of the brain.89 In turn, these 
reward centers affect motivation and have evolved to control human 
behavior that is directed toward survival goals, even in the presence 
of danger.90 Addictive substances “essentially hijack brain circuits that 
exert considerable dominance over rational thought, leading to 
progressive loss of control over drug intake in the face of medical, 
interpersonal, occupational and legal hazards.”91 The continued use of 
addictive substances can physically alter the structure and functioning 
of the brain and result in changes to the brain that remain even after 
the individual has stopped taking the drug.92 Moreover, the disease 
has significant behavioral characteristics; addiction to a substance can 
cause the individual to engage in behavior even when that behavior 
results in unfavorable consequences.93 
There is some debate in the addiction literature about how to 
appropriately characterize the disease of addiction, and “the 
discourse around addiction remains contentious and complex.”94 
 
 88. Dackis & O’Brien, supra note 84, at 1431 (“Much of our knowledge about 
addiction neurobiology is based on decades of animal studies that model the dynamic 
clinical components of the illness.”). 
 89. Id. 
 90. Id. (“Given their function, reward centers have evolved the ability to grip 
attention, dominate motivation and compel behavior directed toward survival goals, even 
in the presence of danger and despite our belief that we are generally rational beings.”). 
 91. Id.; see also Alan I. Leshner, Addiction Is a Brain Disease, ISSUES SCI. & TECH., 
Spring 2001, at 75, 75 [hereinafter Leshner, A Brain Disease] (“It is as if drugs have 
highjacked the brain’s natural motivational control circuits, resulting in drug use becoming 
the sole, or at least the top, motivational priority for the individual.”). 
 92. NAT’L INST. ON DRUG ABUSE, supra note 84, at 5; see also DSM-5, supra note 83, 
at 483 (“An important characteristic of substance use disorders is an underlying change in 
brain circuits that may persist beyond detoxification, particularly in individuals with severe 
disorders.”); Alan I. Leshner, Addiction Is a Brain Disease, and It Matters, 278 SCIENCE 
45, 46 (1997) (“Significant effects of chronic use have been identified for many drugs at all 
levels: molecular, cellular, structural, and functional. The addicted brain is distinctly 
different from the non-addicted brain, as manifested by changes in brain metabolic 
activity, receptor availability, gene expression, and responsiveness to environmental 
cues.”). 
 93. NAT’L INST. ON DRUG ABUSE, supra note 84, at 3. 
 94. Rachel Hammer et al., Addiction: Current Criticism of the Brain Disease 
Paradigm, 4 AM. J. BIOETHICS NEUROSCIENCE 27, 28 (2013); see also Daniel Z. 
Buchman, Wayne Skinner & Judy Illes, Negotiating the Relationship Between Addiction, 
Ethics, and Brain Science, AM. J. BIOETHICS NEUROSCIENCE 36, 42 (2010) (“Neuroethics 
challenges arise when knowledge exclusively from neuroscience is deemed adequate to 
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Some researchers believe that the current emphasis on a brain-disease 
model is a well-intentioned attempt to “debunk[] the moralized 
argument that addiction is a problem for weak-willed people.”95 
These commentators suggest a biological understanding of addiction, 
one that uses biology to explain a condition with social ramifications. 
Viewed in this light, addiction is “a chronic, relapsing, 
biopsychosocial disorder that cannot be understood apart from social 
context” and not simply a brain disease.96 
Further complicating the conversation about addiction as a 
disease is the fact that it is a disease that begins when an individual 
voluntarily engages in substance use, and many “erroneously still 
believe that drug addiction is simply a failure of will or of strength of 
character.”97 And even if we accept that addiction is a disease of the 
brain, it is still the case that the addicted individual has a significant 
role to play both in her illness and her recovery. Yet, while it is true 
that “having this brain disease does not absolve the addict of 
responsibility for his or her behavior, .	.	. it does explain why an addict 
cannot simply stop using drugs by sheer force of will alone.”98 The 
literature on addiction also overwhelmingly supports the need for a 
“much more sophisticated approach to dealing with the array of 
problems surrounding drug abuse and addiction in our society.”99 
Even in the face of this ongoing debate about the definition of 
addiction, however, “the majority of the biomedical community now 
considers addiction, in its essence, to be a brain disease: a condition 
caused by persistent changes in brain structure and function.”100 And 
whether we characterize addiction as a brain disease, a 
 
obtain a full understanding of a mental health disorder as complex as addiction. While the 
practicality of a biopsychosocial systems model may allow for a more integrative 
explanation for addiction, it does not explain addiction entirely.”). 
 95. Hammer et al., supra note 94, at 28. This article describes the concept of 
“othering” as a way in which human groups react to other “groups of people who exhibit 
unfavorable behavior or characteristics against the backdrop of cultural norms” and 
argues that “[t]hose who believe that diseasing addiction will reduce stigma fail to 
recognize how disease itself has its own stigma; the diseased are often just as set apart as 
‘wretches’ and ‘sinners.’” Id. at 30. 
 96. Id. at 31 (“We are embodied beings. Biologically, that addiction rests on a 
neurochemical platform is evident and potentially useful. However, it is not necessary to 
frame addiction as a disease to access the benefits from biological addiction research.”); 
see also Buchman et al., supra note 94, at 37 (advocating “a biopsychosocial systems model 
of, and approach to, addiction, in which psychological and sociological factors complement 
and are in a dynamic interplay with neurobiological and genetic factors”). 
 97. Leshner, A Brain Disease, supra note 91, at 76. 
 98. Id. 
 99. Id. 
 100. Id. at 75. 
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biopsychosocial disorder, or “somewhere in a middle ground,”101 
clinicians diagnose addiction using behavioral components. This 
diagnosis—like all other mental health diagnoses—is made using the 
Diagnostic and Statistical Manual, or DSM-5.102 
According to the DSM-5 diagnostic criteria, individuals can be 
diagnosed with a “substance use disorder” on a continuum from mild 
to severe.103 Unlike older versions of the DSM, the most recent 
edition does not distinguish among substances, and almost all 
substances are diagnosed using the same set of behavioral criteria.104 
Significantly, the DSM-5 does not use the word “addiction”; although 
the word “addiction” is often used to describe “severe problems 
related to compulsive and habitual use of substances,” the DSM-5 
uses the “more neutral term substance use disorder .	.	. to describe the 
wide range of the disorder, from a mild form to a severe state of 
chronically relapsing, compulsive drug taking.”105 
Perhaps mindful of the historical stigma associated with 
substance use, the authors of the DSM-5 chose to eliminate the word 
“addiction” “because of its uncertain definition and its potentially 
negative connotation.”106 Similarly, and despite its longstanding 
inclusion in the DSM, substance use disorder and its treatment have 
 
 101. Hammer et al., supra note 94, at 27. As one author frankly notes, 
The United States is stuck in its drug abuse metaphors and in polarized arguments 
about them. Everyone has an opinion. .	.	. People see addiction as either a disease 
or as a failure of will. None of this bumper sticker analysis moves us forward. The 
truth is that we will make progress in dealing with drug issues only when our 
national discourse and our strategies are as complex and comprehensive as the 
problem itself. 
Leshner, A Brain Disease, supra note 91, at 75. 
 102. See DSM-5, supra note 83, at 483. The DSM is used by clinicians to identify and 
diagnose mental illness. The new version eliminated the separate diagnoses of substance 
“dependence” and “abuse” and replaced them with a single diagnosis of substance use 
disorder. AM. PSYCHIATRIC ASS’N, SUBSTANCE-RELATED AND ADDICTION DISORDERS 
1 (2013) [hereinafter SUBSTANCE-RELATED AND ADDICTION DISORDERS], 
https://www.psychiatry.org/File%20Library/Psychiatrists/Practice/DSM/APA_DSM-5-
Substance-Use-Disorder.pdf [https://perma.cc/8GYK-R7WA]. 
 103. DSM-5, supra note 83, at 484 (“Substance use disorders occur in a broad range of 
severity, from mild to severe, with severity based on the number of symptom criteria 
endorsed.”). 
 104. As the DSM-5 notes, “the diagnosis of a substance use disorder can be applied to 
all 10 classes included in this chapter except caffeine. For certain classes some symptoms 
are less salient, and in a few instances not all symptoms apply.” Id. at 483. The ten classes 
of addictive substances referenced in the DSM-5 include alcohol, caffeine, cannabis, 
hallucinogens, inhalants, opioids, sedatives, stimulants, and tobacco, among others. Id. at 
482. 
 105. Id. at 485. 
 106. Id. 
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been historically marginalized “as a social problem rather than 
[treated] as a medical condition.”107 In fact, few people who engage in 
either risky use or abuse of substances receive adequate, ongoing, 
evidence-based treatment.108 
Like treatment for other chronic diseases, “best practices for the 
effective treatment and management of addiction must be consistent 
with the scientific evidence of the causes and course of the disease.”109 
Evidence-based addiction treatment requires an initial 
comprehensive assessment of the patient, including a thorough 
history, physical exam, and psychosocial evaluation.110 Next, and 
before treatment begins, patients should be stabilized and receive 
medical management of withdrawal, or detoxification, if necessary.111 
The patient should then receive acute treatment, which should be 
provided by qualified health care professionals and should include 
treatment for any co-occurring physical or mental health conditions.112 
Next, the individual should receive chronic disease management to 
assist with maintenance of the progress achieved during treatment 
and to help prevent relapse.113 Finally, the patient should receive 
support services, which include wraparound services in the 
community, like legal, educational, employment, and housing 
support, and community-based mutual support programs.114 
Despite our growing understanding of effective treatment for 
addiction, few people with a substance use disorder receive 
appropriate and ongoing evidence-based treatment.115 Unlike 
treatment for other mental health conditions, which is based on best 
 
 107. NAT’L CTR. ON ADDICTION & SUBSTANCE ABUSE AT COLUMBIA UNIV., supra 
note 85, at 4 (“This profound gap between the science of addiction and current practice 
related to prevention and treatment is a result of decades of marginalizing addiction as a 
social problem rather than treating it as a medical condition.”). 
 108. Id. at 131. 
 109. Id. at 9; see also AM. SOC’Y OF ADDICTION MED., PUBLIC POLICY STATEMENT ON 
TREATMENT FOR ALCOHOL AND OTHER DRUG ADDICTION 2 (2010), 
https://www.asam.org/docs/default-source/public-policy-statements/1treatment-4-aod-1-10.	
pdf?sfvrsn=4d7d8b19_0 [https://perma.cc/Y3EA-9SK4]. 
 110. AM. SOC’Y OF ADDICTION MED., supra note 109, at 2; see also NAT’L CTR. ON 
ADDICTION & SUBSTANCE ABUSE AT COLUMBIA UNIV., supra note 85, at 9. 
 111. NAT’L CTR. ON ADDICTION & SUBSTANCE ABUSE AT COLUMBIA UNIV., supra 
note 85, at 9; see also AM. SOC’Y OF ADDICTION MED., supra note 109, at 2. 
 112. NAT’L CTR. ON ADDICTION & SUBSTANCE ABUSE AT COLUMBIA UNIV., supra 
note 85, at 9; see also AM. SOC’Y OF ADDICTION MED., supra note 109, at 2. 
 113. NAT’L CTR. ON ADDICTION & SUBSTANCE ABUSE AT COLUMBIA UNIV., supra 
note 85, at 9; see also AM. SOC’Y OF ADDICTION MED., supra note 109, at 2. 
 114. NAT’L CTR. ON ADDICTION & SUBSTANCE ABUSE AT COLUMBIA UNIV., supra 
note 85, at 9; see also AM. SOC’Y OF ADDICTION MED., supra note 109, at 2. 
 115. See infra Part IV. 
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practices and administered by highly trained medical professionals, 
the disease of addiction is often treated on the fringes of mainstream 
medicine. The treatment is provided in mutual support programs by 
individuals with little or no medical training and is rarely supervised 
by trained medical professionals.116 Physicians, nurses, and other 
trained medical professionals are typically consulted only when 
necessary.117 Often, individuals who seek out or are ordered into 
treatment receive “brief, episodic interventions,” which might be part 
of the explanation for high rates of relapse among substance 
abusers.118 
Some researchers suggest that this disconnect between 
mainstream medicine and substance use treatment is due to the 
societal stigma of addiction, and that this stigma “contribute[s] to 
policies that would be simply unacceptable if applied to ‘real’ medical 
disorders.”119 Individuals with addiction are often treated not as 
patients but are instead blamed or criminalized for their behavior.120 
In turn, these attitudes are embraced by “[a]n uneducated yet 
strongly opinionated public [that] does not understand the technical 
field of addiction neurobiology and is more likely to conceptualize 
addiction as a character flaw .	.	. than a brain disease.”121 
Instead of receiving evidence-based treatment for their illness, 
many individuals with a substance use disorder therefore go 
untreated, and for some, their first exposure to treatment can come as 
a result of diversion into a drug, alcohol, or mental health court. By 
segregating specialty courts in this way, however, we are further 
stigmatizing addiction and failing to acknowledge that drug and 
alcohol use disorders are one of the many types of mental illnesses 
recognized by the DSM-5.122 Furthermore, individuals who are 
diverted into drug or alcohol court often receive one type of 
 
 116. NAT’L CTR. ON ADDICTION & SUBSTANCE ABUSE AT COLUMBIA UNIV., supra 
note 85, at 212. 
 117. Id. (“Physicians and other medical professionals typically are absent from or on 
the periphery of the treatment process, occasionally being called in to provide a 
prescription or medically monitor a detoxification protocol.”). 
 118. Id. at 7. 
 119. Dackis & O’Brien, supra note 84, at 1431 (“Stigma and misconception create 
formidable obstacles to a more enlightened public policy toward addictive illness.”). 
 120. Id. 
 121. Id. 
 122. For a comprehensive discussion of the stigmatizing effects of the specialty court 
model, see generally Lea Johnson, Theorizing Mental Health Courts, 89 WASH. U. L. REV. 
519, 540–43 (2012) (noting that mental health courts contribute to “impressions about 
offenders with mental illnesses that act synergistically to deepen and reinforce the stigma 
and isolation associated with mental illness”). 
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treatment—substance use treatment—much of which is not evidence 
based and is not delivered in licensed facilities by qualified 
providers.123 Moreover, as discussed in the next part, many of these 
individuals are also likely to meet diagnostic criteria for an additional 
mental health disorder, a diagnosis that may remain unidentified and 
untreated in a traditional drug court. 
III.  PREVALENCE OF CO-OCCURRING MENTAL HEALTH AND 
SUBSTANCE USE DISORDERS 
Comorbidity is so common that dual diagnosis should be 
expected rather than considered an exception.124 
Although many individuals will have some combination of 
mental health and substance use disorder at some point in their 
lifetime,125 this Article focuses on individuals with a co-occurring 
substance use disorder and serious mental illness. As described 
above, substance use disorder refers to abuse or dependence on 
alcohol or illicit drugs and “is used to describe the wide range of the 
disorder, from a mild form to a severe state of chronically relapsing, 
compulsive drug [or alcohol] taking.”126 “Serious mental illness” 
refers to individuals with a mental, behavioral, or emotional disorder 
that substantially interferes with or limits one or more major life 
activities.127 Among individuals with a serious mental illness, “the 
most common and clinically significant” type of co-occurring disorder 
is substance use disorder.128 About 1%, or 2.3 million American 
 
 123. Gordon, supra note 45, at 1539–41.  
 124. Minkoff, supra note 30, at 597. 
 125. See H. Westley Clark et al., Policy and Practice Implications of Epidemiological 
Surveys on Co-Occurring Mental and Substance Use Disorders, 34 J. SUBSTANCE ABUSE 
TREATMENT 3, 4–5 (2008). See generally U.S. DEP’T OF HEALTH & HUM. SERVS., THE 
EVIDENCE: INTEGRATED TREATMENT FOR CO-OCCURRING DISORDERS (2013) 
[hereinafter INTEGRATED TREATMENT], https://store.samhsa.gov/system/files/theevidence-
itc.pdf [https://perma.cc/QED4-GYZF] (discussing effective treatment options for co-
occurring disorders). 
 126. DSM-5, supra note 83, at 485. 
 127. According to the U.S. Department of Health and Human Services, mental illness 
“is the term that refers collectively to all diagnosable mental disorders. Mental disorders 
are health conditions that are characterized by alterations in thinking, mood, or behavior 
(or some combination thereof) associated with distress and/or impaired functioning.” U.S. 
DEP’T. OF HEALTH & HUM. SERVS., MENTAL HEALTH: A REPORT OF THE SURGEON 
GENERAL 5 (1999), https://profiles.nlm.nih.gov/ps/access/NNBBHS.pdf [https://perma.cc/
PG6C-SYYQ]. A serious mental illness is one that “interferes with some area of social 
functioning.” Id. at 46. 
 128. Robert E. Drake et al., A Review of Treatments for People with Severe Mental 
Illnesses and Co-Occurring Substance Use Disorders, 27 PSYCHIATRIC REHABILITATION 
J. 360, 360 (2004) [hereinafter Drake et al., A Review of Treatments] (noting that while 
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adults, had both a serious mental illness and a substance use disorder 
in 2014.129 
Among individuals with a serious mental illness, as many as 40% 
have a co-occurring substance use disorder.130 Similarly, among 
individuals with a substance use disorder, almost half have a co-
occurring mental health disorder.131 Recent research into co-occurring 
disorders supports a strong association between mental health 
disorders and substance use disorders, but “the nature of the 
relationship is complex.”132 For a small number of individuals, one 
disorder can be caused by the other; for instance, long term substance 
use can, in some cases, damage the brain and lead to chronic mental 
health disorders.133 Some studies have also found that the use of 
addictive substances like nicotine, alcohol, or marijuana actually 
increase an individual’s risk for developing a mental health condition 
like anxiety or depression.134 In other cases—particularly in 
 
terms like “dual diagnosis” and “dual disorders” are often used in the literature, they are 
“clearly misnomers, because the individuals with a co-occurring severe mental illness and 
a substance use disorder typically have multiple impairments rather than only two illnesses 
and because there are several other groups with dual diagnoses, such as people with 
developmental disabilities and mental illnesses”). 
 129. SUBSTANCE ABUSE & MENTAL HEALTH SERVS. ADMIN., BEHAVIORAL 
HEALTH TRENDS IN THE UNITED STATES: RESULTS FROM THE 2014 NATIONAL SURVEY 
ON DRUG USE AND HEALTH 33 (2015), https://www.samhsa.gov/data/sites/default/files/
NSDUH-FRR1-2014/NSDUH-FRR1-2014.pdf [https://perma.cc/9YZH-9M5D] (noting 
that 3.3%, or 7.9 million people, met diagnostic criteria for any mental illness and a 
substance use disorder). But see Clark et al., supra note 125, at 5 (“[W]hen treating 
substance use disorders that co-occur with mental illness, the illness can be either severe 
or mild to moderate.”). 
 130. Katherine E. Watkins et al., A National Survey of Care for Persons with Co-
Occurring Mental and Substance Use Disorders, 52 PSYCHIATRIC SERVS. 1062, 1062 
(2001) [hereinafter Watkins et al., A National Survey]; see also Ronald C. Kessler et al., 
The Epidemiology of Co-Occurring Addictive and Mental Disorders: Implications for 
Prevention and Service Utilization, 66 AM. J. ORTHOPSYCHIATRY 17, 25 (1996) (noting in 
a discussion of two different studies, that “the [National Comorbidity Survey] found that 
51% of those with a lifetime addictive disorder also had a lifetime mental disorder, 
compared to 38% in the [Epidemiological Catchment Area]”). 
 131. Watkins et al., A National Survey, supra note 130, at 1062. 
 132. Brady & Sinha, supra note 16, at 1484 (noting that “[s]everal theories have been 
proposed to explain the high co-occurrence”). 
 133. Watkins et al., A National Survey, supra note 130, at 1062. 
 134. Jeffrey G. Johnson et al., Association Between Cigarette Smoking and Anxiety 
Disorders During Adolescence and Early Adulthood, 284 [J]AMA 2348, 2350 (2000) (“Our 
findings are consistent with research suggesting that cigarette smoking may increase risk 
for certain anxiety disorders.”); see also George C. Patton et al., Cannabis Use And Mental 
Health in Young People: Cohort Study, 325 BRIT. MED. J. 1195, 1198 (2002) (“[F]requent 
use of cannabis in young people increases the risks of later depression and anxiety.”); Paul 
Rhode et al., Natural Course of Alcohol Use Disorders from Adolescence to Young 
Adulthood, 40 J. AM. ACAD. CHILD ADOLESC. PSYCHIATRY 83, 83 (2001) (“Adolescent 
[alcohol use disorder], significantly predicted [alcohol use disorder], substance use 
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individuals with mood disorders135—individuals may first develop a 
mental illness and begin using addictive substances as a means of 
treating the symptoms of those disorders, a practice commonly 
referred to as “self-medicating.”136 In the majority of cases, however, 
“the temporal relationships between the disorders and the high 
proportion of primary lifetime conditions suggest that most of them 
are primary independent disorders—that is, one did not cause the 
other.”137 
While rates of co-occurring mental health and substance use 
disorders can vary somewhat across population, substance, and type 
of mental illness, they remain high and consistent within and among 
groups. For instance, rates of a co-occurring substance use disorder 
are high regardless of whether the individual meets diagnostic criteria 
for an anxiety disorder or a mood disorder, like depression.138 Among 
individuals with a current substance use disorder, about 20% also 
 
disorder, depression, and elevated levels of antisocial and borderline personality disorder 
symptoms by age 24.”); Traci L. Steuber & Fred Danner, Adolescent Smoking and 
Depression: Which Comes First?, 31 ADDICTIVE BEHAVS. 133, 136 (2006) (“Results of the 
analyses revealed that adolescents who smoked currently or in the past were more likely 
to experience depression, with regular smokers showing the highest levels of depression, 
even after controlling for previous depression.”). 
 135. Joel Swendsen et al., Mental Disorders as Risk Factors for Substance Use, Abuse 
and Dependence: Results from the 10-Year Follow-Up of the National Comorbidity Survey, 
105 ADDICTION 1117, 1125 (2010) (“The broad categories of any mood or anxiety 
disorder were also associated frequently with the onset of substance dependence over the 
subsequent decade.”). 
 136. Id. (noting that the association of a primary mental illness and an increased risk 
for later substance abuse “may reflect self-medication as well as a number of other causal 
mechanisms”); see also Kessler et al., supra note 130, at 28 (“[S]ubstance abuse occurs as 
an unintended consequence of self-medicating a mental disorder.”); Timothy E. Wilens et 
al., Further Evidence of an Association Between Adolescent Bipolar Disorder with Smoking 
and Substance Use Disorders: A Controlled Study, 95 DRUG AND ALCOHOL 
DEPENDENCE 188, 195 (2008) (“It may be that adolescents self medicate their irritable 
mood, aggressivity, and ‘affective storms’ with substances of abuse or alcohol.”). 
 137. Watkins et al., A National Survey, supra note 130, at 1062. While the correlation 
between mental illness and addiction can be viewed as either a high incident of mental 
illness in individuals with addiction, or as a high incident of addiction in individuals with 
mental illness, “both views suggest that there may be common neurobiological substrates 
for substance abuse and mental disorders.” Nora D. Volkow, What Do We Know About 
Drug Addiction?, 162 AM. J. PSYCHIATRY 1401, 1401 (2005); see also Brady & Sinha, 
supra note 16, at 1484 (“A growing body of evidence from basic science and translational 
studies implicates common neurobiological pathways and abnormalities involved in 
addiction and a number of psychiatric disorders.”). 
 138. At any given time, approximately 19.2 million American adults meet diagnostic 
criteria for a mood disorder, and 23 million meet diagnostic criteria for an anxiety 
disorder. Bridget F. Grant et al., Prevalence and Co-Occurrence of Substance Use 
Disorders and Independent Mood and Anxiety Disorders, 61 ARCHIVES GEN. 
PSYCHIATRY 807, 814 (2004). The numbers are similar for substance use disorder, which 
affects approximately 19.4 million American adults. Id. 
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have an independent mood disorder, and 18% have an independent 
anxiety disorder.139 Similarly, among individuals with a current mood 
disorder, about 20% have a substance use disorder, and among 
individuals with a current anxiety disorder, about 15% also have a 
substance use disorder.140 Even higher numbers are seen in 
individuals with psychotic disorders; one study of 1219 individuals 
with schizophrenia, for instance, found that 54% of the participants 
also met diagnostic criteria for a substance use disorder.141 
Similarly, individuals with “behavioral addictions,” or 
nonsubstance addictions, also have high rates of co-occurring 
disorders.142 For example, a study of problem gamblers found that 
57% of participants also met criteria for a substance use disorder.143 A 
co-occurring substance use disorder may develop concurrently with a 
gambling disorder, or an individual may use gambling as a way to 
alleviate symptoms and cope “with a more general underlying 
psychopathology involving a mood or anxiety disorder.”144 In still 
other individuals, mood disorders are secondary symptoms that occur 
in response to significant financial losses.145 But whether a substance 
 
 139. Id. 
 140. Id. at 814–15. 
 141. Berit Kerner, Comorbid Substance Use Disorders in Schizophrenia: A Latent Class 
Approach, 225 PSYCHIATRY RES. 395, 397 (2015) (“Substance use disorders preceded the 
onset of schizophrenia in about two-third of cases with substance use, and in about one-
third of cases substance use disorders had been diagnosed after the onset of 
schizophrenia.”). 
 142. These types of disorders are “analogous to substance addiction, but with a 
behavioral focus other than ingestion of a psychoactive substance.” Jon Grant et al., 
Introduction to Behavioral Addictions, 36 AM. J. DRUG & ALCOHOL ABUSE 233, 233 
(2010). Apart from gambling disorder, which the most recent edition of the DSM has 
moved to a new section entitled “Non-Substance-Related Disorders,” DSM-5, supra note 
83, at 585–86, these types of behaviors are typically classified as impulse control disorders, 
and include things like kleptomania, Grant et al., supra, at 233. The DSM-5 also created a 
separate section for “Non-Substance-Related Disorders,” which includes gambling 
disorder as its only condition. Id. “Although some behavioral conditions that do not 
involve ingestion of substances have similarities to substance-related disorders, only one 
disorder—gambling disorder—has sufficient data to be included in this section.” DSM-5, 
supra note 83, at 586. As the American Psychiatric Association notes, “[t]his new term and 
its location in the new manual reflect research findings that gambling disorder is similar to 
substance-related disorders in clinical expression, brain origin, comorbidity, physiology, 
and treatment.” SUBSTANCE-RELATED AND ADDICTION DISORDERS, supra note 102, at 
1. 
 143. Felicity K. Lorains et al., Prevalence of Comorbid Disorders in Problem and 
Pathological Gambling: Systematic Review and Meta-Analysis of Population Surveys, 106 
ADDICTION 490, 493 (2010) (noting that among problem gamblers, “57.5% [were also 
diagnosed] for any substance use disorder, 28.1% for alcohol use disorder, 17.2% for illicit 
drug abuse/dependence and 60.1% for nicotine dependence”). 
 144. Id. at 495. 
 145. Id.  
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use disorder or other mental health disorder preceded, developed 
concurrently with, or was a result of problem gambling, the research 
consistently shows that individuals with gambling disorder “have high 
prevalence rates for many comorbid disorders.”146 
Finally, studies examining specific populations also find high 
rates of co-occurring substance use and mental health disorders. For 
example, one study of veterans returning from wars in Iraq and 
Afghanistan found that of 103,788 users of U.S. Department of 
Veterans Affairs services, 25% sought treatment for a mental health 
condition, and many sought services for multiple mental health 
disorders.147 Veterans most often sought services for PTSD,148 which 
similarly “has a high co-occurrence with other mental health 
diagnoses.”149 Among individuals with PTSD, rates of co-occurring 
depression are between 48% and 60%, and rates of substance use 
disorder are between 34% and 88%.150 As one author noted, “[t]hese 
results indicate a large burden of co-occurring mental health disorders 
associated with service in Iraq and Afghanistan.”151 
These are only a few examples. A review of the literature reveals 
hundreds of studies detailing high and consistent rates of co-occurring 
mental health and substance use disorders, rates that hold across 
disorder, substance, and population.152 Furthermore, individuals with 
co-occurring disorders have higher morbidity and mortality rates, and 
treatment for more than one disorder can be difficult to coordinate.153 
Yet the research consistently demonstrates that integrated treatment 
programs are more effective and have better outcomes for patients 
 
 146. Id. at 496. 
 147. Karen H. Seal et al., Bringing the War Back Home: Mental Health Disorders 
Among 103,788 US Veterans Returning from Iraq and Afghanistan Seen at Department of 
Veterans Affairs Facilities, 167 ARCHIVES INTERNAL MED. 476, 478 (2007) (“The median 
number of different diagnoses was 3 .	.	. ; 44% had a single mental health diagnosis, 29% 
had 2 different diagnoses, and 27% had 3 or more different mental health diagnoses.”). 
 148. Id. (“The single most common mental health diagnosis was PTSD .	.	.	, 
representing 52% of those receiving mental health diagnoses.”). 
 149. Tracy Stecker et al., Co-Occurring Medical, Psychiatric, and Alcohol-Related 
Disorders Among Veterans Returning from Iraq and Afghanistan, 51 PSYCHOSOMATICS 
503, 504 (2010). 
 150. Id. (citing various studies). 
 151. Seal et al., supra note 147, at 479. 
 152. For an excellent review of the research literature on co-occurring disorders and 
appropriate treatment, see INTEGRATED TREATMENT, supra note 125, at 1–5. 
 153. Katherine E. Watkins et al., Prevalence and Characteristics of Clients with Co-
Occurring Disorders in Outpatient Substance Abuse Treatment, 30 AM. J. DRUG & 
ALCOHOL ABUSE 749, 750 (2004). 
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than programs that focus on only one disorder.154 As discussed in the 
next part, however, individuals with co-occurring disorders who enter 
treatment often encounter a segregated treatment system—if they 
encounter one at all—and few practitioners are trained in the 
appropriate and effective treatment of this population. 
IV.  INTEGRATED TREATMENT AND BARRIERS TO TREATMENT 
Although integrated dual diagnosis services and other evidence-
based practices are widely advocated, they are rarely offered in 
routine mental health treatment settings. The barriers are 
legion.155 
A recent review of twenty-six controlled studies of treatment for 
co-occurring mental health and substance use disorders found that the 
most effective treatments for co-occurring disorders “are integrated, 
which means that they combine mental health and substance abuse 
interventions at the clinical interface.”156 In an integrated treatment 
setting, individuals receive appropriate mental health and substance 
abuse treatment from a single clinician or clinical team.157 Because the 
clinical team is responsible for providing cohesive treatment, the 
individual experiences the treatment as “singular, because it entails a 
consistent approach, philosophy, and set of recommendations.”158 
When clinicians take responsibility for providing a cohesive set of 
services to patients, mental health and substance abuse interventions 
are therefore better coordinated and more accessible to patients. 
Treatment within a coordinated system allows providers to 
“modify[] as well as combin[e] the treatments for both disorders” in a 
 
 154. Robert E. Drake et al., Implementing Dual Diagnosis Services for Clients with 
Severe Mental Illness, 52 PSYCHIATRIC SERVS. 469, 471 (2001). 
 155. Id. at 472–73. 
 156. Drake et al., A Review of Treatments, supra note 128, at 367 (“Despite enormous 
variance in designs, interventions, and outcome measures, several consistent themes 
appear across the studies and thus emerge as principles of care. The most consistent 
finding across recent studies is that effective dual disorders treatments are integrated.”); 
see also Clark et al., supra note 125, at 7 (“There is growing consensus that for COD 
treatment to be effective, mental health and substance abuse interventions should be 
integrated at the clinical interface.”); Susan Foster et al., Services and Supports for 
Individuals with Co-Occurring Disorders and Long-Term Homelessness, 37 J. BEHAV. 
HEALTH SERVS. & RES. 239, 241 (2010) (“Although the treatment field has not coalesced 
to define the specific practices and interventions to serve the full range of client 
populations with COD, integrated treatment for persons with severe levels of psychiatric 
and substance use issues has received strong research support.”).  
 157. Drake et al., A Review of Treatments, supra note 128, at 367. 
 158. Id. (noting that in an integrated system, patients “are not required to negotiate 
with separate clinical directives, teams, programs, or treatment systems”). 
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way that helps individuals address both conditions.159 For example, 
when an individual with a serious mental illness receives substance 
abuse counseling, that treatment should be “slower, less 
confrontational, more repetitive, more focused on motivation, and 
more behavioral than what is provided in many traditional substance 
abuse treatment settings .	.	.	.”160 Similarly, individuals who receive 
pharmacological treatments for one or both disorders will often need 
to be prescribed medications that pose less risk for abuse or drug 
interactions.161 
Despite what we know about effective and integrated treatment 
for individuals with co-occurring disorders, however, a recent study 
by the U.S. Department of Health and Human Services found that of 
the four million American adults with a co-occurring substance use 
and mental health disorder, about half of them received some type of 
treatment, either for substance use or mental illness, but only 11.8% 
received treatment for both conditions.162 Another study put the 
number slightly lower, finding that “[d]espite the recommendation 
that individuals who have co-occurring disorders receive treatment 
for both their mental health and substance use problems, only 8 
percent received either integrated or parallel treatment.”163 Not 
surprisingly, treatment rates are lowest in traditionally underserved 
groups, including people with low incomes and no health insurance, 
elderly people, racial and ethnic minorities, and people in rural 
areas.164 
Part of the reason for low rates of integrated treatment stems 
from the bifurcation of mental health and addiction services, a divide 
 
 159. Id. at 367. 
 160. Id. (recognizing “the special needs of many individuals with severe mental 
illnesses”). 
 161. See Jean-Michel Azorin et al., Pharmacological Treatment of Schizophrenia with 
Comorbid Substance Use Disorder, 17 EXPERT OPINION ON PHARMACOTHERAPY 231, 
231–32 (2016); Lana A. Vornik et al., Management of Comorbid Bipolar Disorder and 
Substance Abuse, 67 J. CLINICAL PSYCHIATRY 24, 24–26 (2006). 
 162. EPSTEIN ET AL., U.S. DEP’T OF HEALTH & HUM. SERVS., SERIOUS MENTAL 
ILLNESS AND ITS CO-OCCURRENCE WITH SUBSTANCE USE DISORDERS 2–3 (2002), 
http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.361.9429&rep=rep1&type=pdf 
[https://perma.cc/Y2UW-J3X7].  
 163. Watkins et al., A National Survey, supra note 130, at 1066; see also Clark et al., 
supra note 125, at 6 (finding that of the 5.2 million American adults identified as having 
co-occurring substance use and mental health disorders, “[o]nly 8.5% received treatment 
for both their mental health and substance use problems”); Foster et al., supra note 156, at 
240. 
 164. Clark et al., supra note 125, at 5 (citing Wang et al., Twelve-Month Use of Mental 
Health Services in the United States: Results from the National Comorbidity Survey 
Replication, 62 ARCHIVES GEN. PSYCHIATRY 629, 629 (2005)). 
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one author describes as “two distinct and heavily bounded 
territories.”165 Instead of receiving treatment for both conditions, 
individuals with co-occurring disorders “tend to be assigned to one 
system or the other, which would view them through its own 
particular lens .	.	.	.”166 This divide between mental health and 
addiction services has created structural barriers to integrated 
treatment that can prevent or reduce the likelihood that people with 
both addiction and mental illness will receive care.167 In particular, 
individuals seeking treatment for a co-occurring mental health and 
substance use disorder are often unable to find providers in their 
geographic area or are unable to find providers trained in the 
integrated treatment of co-occurring disorders. 
Many individuals who need treatment for a co-occurring mental 
illness and substance use disorder are simply unable to find or access 
available services. This lack of services is particularly pronounced in 
rural areas, where “medical providers .	.	. often fail to address co-
occurring disorders .	.	.	.”168 Even in larger areas, however, there are 
few available treatment providers for co-occurring disorders and few 
residential or rehabilitation programs geared toward individuals with 
co-occurring disorders.169 A recent study interviewed clinicians with 
experience in treating patients with co-occurring substance use and 
mental health disorders, many of whom “expressed frustration about 
the lack of integrated psychiatric and substance use treatment, and 
patients falling into the gap between the two services.”170 
 
 165. Davidson & White, supra note 18, at 110 (describing the “importance of providing 
integrated care for persons with co-occurring disorders” and obstacles to integration that 
range from “historical, political, ideological, professional, and fiscal/structural issues at one 
end of the spectrum .	.	. to practical and logistical issues at the other end”). 
 166. Robert E. Drake et al., A Systematic Review of Psychosocial Research on 
Psychosocial Interventions for People with Co-Occurring Severe Mental and Substance Use 
Disorders, 34 J. SUBSTANCE ABUSE TREATMENT 123, 123 (2008) (noting that “[s]uch 
problems continue in the fragmented U.S. healthcare system”). 
 167. Priester et al., supra note 3, at 56. 
 168. Ronald D. Hester, Integrating Behavioral Health Services in Rural Primary Care 
Settings, 25 SUBSTANCE ABUSE 63, 63 (2004) (“Substance abuse and mental health 
services treatment options in small towns are often very limited.”). Furthermore, many 
individuals in rural areas have little access to transportation, making it even more difficult 
to access services. Priester et al., supra note 3, at 55 (“Geographic proximity to services 
and lack of transportation or resources to obtain transportation to reach these limited 
services are commonly cited in the literature as a barrier to treatment access.”). 
 169. Id. at 55 (“A primary barrier to treatment access for individuals with COD is 
service availability.”). 
 170. Kate B. Carey et al., Treating Substance Abuse in the Context of Severe and 
Persistent Mental Illness: Clinicians’ Perspectives, 19 J. SUBSTANCE ABUSE TREATMENT 
189, 195 (2000). As one clinician noted,  
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Other clinicians identified a need for more training for health 
care professionals who work with individuals with co-occurring 
disorders.171 Mental health treatment providers and substance use 
treatment providers receive vastly different types of training, 
“probably because health care professionals often were not interested 
in treating addiction problems,”172 and few receive training in both 
fields.173 Many addiction treatment providers have little or no medical 
training, and in many cases their only qualification is a personal 
history of addiction.174 Even among medical doctors, “most 
psychiatric programs do not provide training in co-morbid disorders 
and many family practice residents do not feel confident in discussing 
substance use issues with their patients.”175 And while medical schools 
 
[W]e’re not a substance abuse treatment center so that when we’re doing this 
work, it’s over and above the mental health treatment. And [it involves] resource 
stretching. .	.	. Oh, yeah, let’s add this other layer of treatment that we’re not 
licensed for, we don’t get paid for. .	.	. That makes it tough. 
Id. (alterations in original); see also Watkins et al., A National Survey, supra note 130, at 
1062 (“Substance abuse and mental health treatment programs are funded and managed 
separately, and coordination of treatment regimens across established bureaucracies has 
been difficult.”). 
 171. Even among clinicians with experience in treating this population, much of the 
training they have received is informal. As one person in the Carey study stated, “One 
[method] is taking a lot of workshops and courses. .	.	. The other [method] is investment in 
my own recovery and doing a lot of reading in the area and thinking about it. And third is 
just experience and just trying to keep my own eyes open.” Carey et al., supra note 170, at 
192. 
 172. Mary Louise E. Kerwin et al., Comparative Analysis of State Requirements for the 
Training of Substance Abuse and Mental Health Counselors, 30 J. SUBSTANCE ABUSE 
TREATMENT 173, 173 (2006); see also Dackis & O’Brien, supra note 84, at 1431 
(“Pejorative views toward addictive individuals also exist and contribute to policies that 
would be simply unacceptable if applied to ‘real’ medical disorders.”); Elizabeth H. 
Hawkins, A Tale of Two Systems: Co-Occurring Mental Health and Substance Abuse 
Disorders Treatment for Adolescents, 60 ANN. REV. PSYCHOL. 197, 204 (2009) 
(“Traditional behavioral health treatment in this country revolves around separate and 
often disconnected systems.”). 
 173. Hawkins, supra note 172, at 204 (“In general, conceptualizations of illness and 
corresponding treatment philosophies are strikingly different, and required educational 
backgrounds, training experiences, and licensing requirements vary widely between 
mental health and substance abuse sectors.”). 
 174. NAT’L CTR. ON ADDICTION & SUBSTANCE ABUSE AT COLUMBIA UNIV., supra 
note 85, at 176. 
 175. Priester et al., supra note 3, at 55. While the American Psychiatric Association’s 
official position statement on substance use disorders recognizes that “[s]creening and 
brief intervention for substance use disorders, which frequently co-occur with other 
psychiatric disorders, should be a routine part of medical assessment,” AM. PSYCHIATRIC 
ASS’N, POSITION STATEMENT ON SUBSTANCE USE DISORDERS ¶	1 (2012), 
https://www.psychiatry.org/File%20Library/About-APA/Organization-Documents-Policies/
Policies/Position-2012-Substance-Use-Disorders.pdf [https://perma.cc/6HA5-5A63], the 
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and psychiatry programs have increased training for substance use 
disorders, most still fail to address the needs of patients with co-
occurring disorders.176 Finally, there are few opportunities for cross-
training and few incentives or resources for practitioners to seek out 
dual certification.177 As one author noted, there are few accepted 
models for co-occurring disorders specialists, and “becoming dually 
certified or licensed is an onerous burden that most do not 
undertake.”178 
Because of this lack of cross-training among addiction treatment 
and mental health care providers, there is a corresponding lack of 
providers with experience in co-occurring disorders and fewer 
resources available to individual patients.179 Moreover, because they 
lack training in both fields, many treatment providers “may identify a 
substance use disorder or a mental health disorder but not the co-
occurrence of both.”180 Underidentification of co-occurring disorders 
means that few patients “who could benefit from treatment receive it, 
and those who do often get it after their problems are severe and co-
occurring with medical and psychiatric conditions.”181 
Our historically bifurcated approach toward the treatment of 
mental illness and substance use disorders has therefore created 
entrenched structural barriers to integrated treatment. As a result, 
many individuals who attempt to access treatment for co-occurring 
 
majority of psychiatry residencies “do not provide adequate training in the management of 
complicated patients with these comorbid disorders,” John A. Renner, Jr., How to Train 
Residents to Identify and Treat Dual Diagnosis Patients, 56 BIOLOGICAL PSYCHIATRY 810, 
810 (2004). 
 176. Renner, supra note 175, at 810 (“Psychiatry training in the United States has 
failed to adequately address the needs of patients with comorbid substance use disorders 
(SUD) and major psychiatric disorders. .	.	. Medical schools rarely provide adequate 
training in the management of these patients.”); Stacy Sterling et al., Access to Treatment 
for Adolescents with Substance Use and Co-Occurring Disorders: Challenges and 
Opportunities, 49 J. AM. ACAD. CHILD & ADOLESCENT PSYCHIATRY 637, 641 (2010) 
(noting that medical providers “rarely receive adequate training to manage [substance 
use] problems, and even less to manage co-occurring problems”). 
 177. Hawkins, supra note 172, at 204. 
 178. Id. 
 179. Id. (“As a result, few providers at the local level are knowledgeable and capable 
of treating co-occurring disorders.”). 
 180. Priester et al., supra note 3, at 55; see also Alan I. Green et al., Schizophrenia and 
Co-Occurring Substance Use Disorder, 164 AM. J. PSYCHIATRY 402, 403 (2007) (“Co-
occurring substance use disorders are often underdetected and undertreated in mental 
health settings, where the traditional separation between mental health and substance 
abuse training programs and service delivery systems results in a lack of knowledge about 
co-occurring disorders .	.	.	.”). 
 181. Sterling et al., supra note 176, at 638 (noting that “[t]hey are then more difficult to 
treat, and more expensive to health care systems”). 
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disorders “frequently fall through the cracks” between the two 
systems.182 And while one clear barrier to integrated treatment is the 
lack of trained providers, another less obvious structural barrier is the 
organization—and segregation—of drug, alcohol, and mental health 
courts. 
Many individuals receive mental health or substance use 
treatment as a result of their diversion into a specialty court. And 
while these courts claim to have created a revolution in the criminal 
justice system, their basic organizational structure has not kept pace 
with what we now know about the appropriate—and integrated—
treatment of co-occurring mental health and substance use disorders. 
As discussed in the next part, if specialty courts are to stay on the 
cutting edge of criminal justice reform, they must take a bigger role in 
the identification and treatment of individuals with co-occurring 
disorders who are diverted out of the criminal justice system. In this 
way, specialty courts can help improve the often fragmented and 
confusing treatment system encountered by individuals with co-
occurring mental illness and substance use disorders. 
V.  TOWARD INTEGRATED TREATMENT IN DRUG AND MENTAL 
HEALTH COURTS 
The drug court model is ubiquitous, and many individuals will 
become involved in a drug or other specialty court in the United 
States each year. In its most recent Census of Problem-Solving 
Courts, the Department of Justice counted 3052 specialty courts in 
the United States, 44% of which were drug courts and 11% of which 
were mental health courts.183 Moreover, there are an additional 400 
DWI and hybrid DWI/drug courts, which together comprise 
approximately 13% of all specialty courts.184 Although alcohol and 
DWI courts are technically distinct from drug courts, this Article uses 
the general term “drug court” to encompass both traditional drug 
 
 182. Clark et al., supra note 125, at 6. 
 183. STRONG ET AL., supra note 26, at 1. As of the 2012 census, only Connecticut, 
Kansas, Nebraska, North Dakota, Puerto Rico, Rhode Island, South Dakota, West 
Virginia, and Wyoming did not have at least one mental health court. Id. at 3–4. Every 
state has at least one drug court, and many states have dozens of such courts, including 
California with eighty-three, Florida with sixty-eight, Missouri with sixty-two, and New 
York with fifty. Id. 
 184. Id. at 1 fig.1 (counting 183 DWI courts and 217 hybrid DWI/drug courts). DWI 
courts “focus on changing the behavior of the alcohol-dependent offender or offenders 
with a high blood alcohol content who were arrested for DWI or driving under the 
influence,” while hybrid DWI/drug courts “handle alcohol or drug-dependent offenders 
who have also been charged with a driving offense.” Id. at 2. 
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courts and these other alcohol and DWI courts, which “focus on 
changing the behavior of the alcohol-dependent offender .	.	.	.”185 
Given their large numbers and diverse locations, it is not 
surprising that individual specialty courts vary tremendously.186 
Moreover, due in part to the many varieties of specialty courts, 
individual courts employ vastly different structures and procedures, 
leading some researchers to describe specialty courts as a kind of 
“black box.”187 As one author noted, “when you’ve seen one mental 
health court, you’ve seen one mental health court.”188 Other 
researchers have suggested that the roots of the drug court 
movement—which was developed by individual judges and without 
an underlying theoretical model—are in some ways responsible for 
this lack of consistent structure.189 
This lack of uniform structure extends to the selection of 
specialty court participants. While eligibility and placement 
requirements are often dictated by statute, they vary tremendously 
from court to court, and other aspects of the specialty court model are 
far less transparent. In particular, it is difficult to ascertain the specific 
procedures by which individuals are sorted into a particular specialty 
court. In many jurisdictions, referral into a drug court is generally up 
to the prosecutor,190 and drug courts primarily accept individuals 
 
 185. Id. 
 186. For an excellent overview of the history of drug courts and the similarities and 
differences among various courts, see NOLAN, supra note 27, 39–60. 
 187. Jeff Bouffard & Faye Taxman, Looking Inside the “Black Box” of Drug Court 
Treatment Services Using Direct Observations, 34 J. DRUG ISSUES 195, 195 (2004); John S. 
Goldkamp, Michael D. White & Jennifer B. Robinson, Do Drug Courts Work? Getting 
Inside the Drug Court Black Box, 31 J. DRUG ISSUES 27, 27 (2001); Deborah Koetzle 
Shaffer, Looking Inside the Black Box of Drug Courts: A Meta-Analytic Review, 28 JUST. 
Q. 493, 493 (2010). 
 188. Ursula Castellano & Leon Anderson, Mental Health Courts in America: Promise 
and Challenges, 57 AM. BEHAV. SCI. 163, 170 (2013); see also Bean, supra note 68, at 720 
(“What one finds is that there are as many variations in the locus of Drug Courts within 
the legal system as there are Drug Courts themselves.”). 
 189. Shaffer, supra note 187, at 494–95 (2010) (“The lack of a theoretical model during 
the model’s infancy, coupled with a lack of guidance on how to implement the key 
components resulted in considerable inconsistency in the structure of the model across 
jurisdictions.”); see also Hora et al., supra note 37, at 449 (“Few early [drug court] 
practitioners worried about the jurisprudential theory behind the [drug court] movement. 
[Drug courts] seemed to work, and the absence of analysis or debate coming from the 
‘ivory towers’ of academia about the efficacy of drug treatment in a criminal justice setting 
did not much matter.”). 
 190. See, e.g., People v. Sturiale, 98 Cal. Rptr. 2d 865, 867 (Cal. Ct. App. 2000) (noting 
that the prosecutor has sole discretion under California law to determine eligibility for a 
drug court program); State v. Upshaw, 648 So. 2d 851, 852 (Fla. Dist. Ct. App. 1995) 
(noting that “the law is well settled that the State Attorney has the sole discretion to 
prosecute” and “offer [the defendant] a drug court program”). 
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charged with drug crimes.191 In mental health courts, however, many 
referrals come from the prosecutor, but referrals may also come from 
other judges, treatment providers, family members, or even staff 
members at the county jail.192 
An individual with a co-occurring disorder may therefore be 
assigned to a mental health court or a drug court based in large part 
on the crime that led to her arrest or by the source of her referral. In 
many cases, however, if an individual with a co-occurring mental 
health and substance use disorder is charged with a drug crime or 
with driving while intoxicated, they are likely to be referred to a drug 
court or a DWI court, with little attention given to the possible 
presence of multiple disorders. Moreover, judges and court personnel 
in these segregated courts have differing levels of expertise and 
knowledge of available community resources. Specialty court 
participants with co-occurring disorders may (or may not) receive 
treatment for each disorder, but the focus of their rehabilitation will 
in many cases depend simply on the particular specialty court they 
enter. Appropriate and integrated treatment therefore becomes a 
game of chance for many specialty court participants.  
Perhaps mindful of the limitations of segregated specialty courts 
and the high rates of co-occurring disorders, a handful of jurisdictions 
have established “co-occurring disorder courts,” though these appear 
to be the exception rather than the rule. Although it is difficult to 
identify exact numbers, there appears to be four specialty courts 
around the country that are explicitly devoted to serving individuals 
with co-occurring disorders. The Jasper County, Missouri, Co-
Occurring Disorder Court, for example, admits defendants who “have 
a mental illness and substance abuse disorder which is related to their 
current charge and/or for whom mental health [and] substance abuse 
treatment in a court supervised program can be expected to foster 
 
 191. U.S. DEP’T OF JUSTICE, supra note 28, at 9. Similarly, DWI and hybrid DWI/drug 
courts generally accept alcohol- or drug-dependent offenders who have been charged with 
a driving offense. STRONG ET AL., supra note 26, at 2. 
 192. See ALMQUIST & DODD, supra note 29, at 15 (citing various studies). Similarly, 
“any interested party may request that a criminal case be transferred” to a Boston Mental 
Health Court. W. ROXBURY DIV. OF THE BOS. MUN. COURT, RECOVERY WITH JUSTICE 
PROGRAM: MENTAL HEALTH SESSION, http://www.mass.gov/courts/docs/specialty-courts/
mental-health-court-brochure.pdf [https://perma.cc/9LLG-BACP]. In other specialty courts, 
referral to a particular court appears to be self-directed. In Nevada, for instance, veterans 
“can be self-referred, their attorneys may refer them, or other judges and other 
jurisdictions may refer them” to veterans court. Robert Horne, Nevada Veteran’s Specialty 
Courts, NEV. L., Nov. 2016, at 25, 25. Signs are posted on courtroom doors asking veterans 
“to please notify their public defender or attorney if they are a veteran” so the court can 
be made aware of potential candidates for the Veterans Treatment Court. Id. 
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recovery and reduce recidivism.”193 Similarly, Maine has created a co-
occurring disorder court that admits “adults with significant substance 
abuse disorders and mental illnesses and serious criminal charges.”194 
The remaining two co-occurring disorder courts—in Reno, 
Nevada, and Los Angeles County, California—limit eligibility to 
misdemeanor and drug charges, respectively. For example, the Reno, 
Nevada, Misdemeanor Co-Occurring Mental Health and Substance 
Abuse Disorder Specialty Court only accepts low-level offenders, 
limiting eligibility to offenders “who appeared for misdemeanor 
charges and exhibited or had a previous diagnosis of a mental health 
condition coupled with alcohol or other drug use .	.	.	.”195 The Los 
Angeles County Co-Occurring Disorders Court appears to be 
directed toward the city’s homeless population and limits eligibility to 
“non-violent felony drug offenders who have both a severe, chronic 
substance abuse disorder and serious, persistent mental illness are 
homeless or at risk for homelessness and have had frequent contacts 
with the criminal justice system.”196 Although these courts’ 
recognition of individuals with co-occurring disorders is 
commendable, many critics argue that this type of cherry picking of 
court participants excludes individuals who would benefit most from 
participation in the court197 and also discriminates against people of 
color.198 
 
 193. 29TH JUDICIAL CIRCUIT, JASPER COUNTY CO-OCCURRING DISORDERS COURT 
PARTICIPANT’S MANUAL 3 (2017), http://www.jaspercounty.org/pdf/courts/treatmentcourt/
CoOccuringManual.pdf [https://perma.cc/865Y-uzvl]. 
 194. Maine Co-Occurring Disorders and Veterans Court, ST. ME. JUD. BRANCH 
http://www.courts.maine.gov/maine_courts/drug/codvc.html [https://perma.cc/6WBL-Z8DD]. 
Even this innovative court, however, further segregates participants into two tracks: 
participants are assigned to either civilian or veteran’s co-occurring disorders court, in 
recognition of the fact that “criminal conduct as well as behavioral disorders may be 
attributable to their service .	.	.	.” Id. 
 195. KEVIN CROWE, RENO MUN. COURT, CO-OCCURRING DISORDER SPECIALTY 
COURT (COD) PROGRAM EVALUATION REPORT 3 (2014), https://www.reno.gov/home/
showdocument?id=48292 [https://perma.cc/PJ8Y-PNQS]. 
 196. CTY. OF L.A. DEP’T OF PUB. HEALTH, CO-OCCURRING DISORDERS COURT 
PROGRAM FACT SHEET, http://www.publichealth.lacounty.gov/sapc/resources/Co-
OccurringDisorderCourt.pdf [https://perma.cc/9EJT-NNQT]. 
 197. JUSTICE POLICY INST., supra note 24, at 21 (“Drug courts that receive federal 
discretionary grants are required to focus on people accused of nonviolent offenses and 
those without a violent record. Yet research shows that drug courts have the greatest 
benefit for people who have more prior felony convictions and have previously failed 
other dispositions.”). 
 198. Id. (“Since people of color are more likely to have a felony conviction on their 
record at the time of an arrest related to drug abuse, they are more likely to be excluded 
from consideration for drug court participation.”); see also Josh Bowers, Contraindicated 
Drug Courts, 55 UCLA L. REV. 783, 807 (2008) (“Consequently, addicts, minorities, and 
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Despite some of these drawbacks, however, the existence of 
these few co-occurring disorder courts is one example of the progress 
that we have seen in the integration of mental health and substance 
use treatment systems in communities around the country. The 
mental health system has begun “providing or encouraging training in 
[alcohol and drug] problems for some time, and the general level of 
skill of practitioners is improving.”199 At the same time, many 
addiction treatment providers now have a better understanding of 
how to treat individuals who have a co-occurring mental illness.200 
Notwithstanding these advances, however, “[a]rtifacts of the 
structural and organizational disconnect between the mental health 
and substance abuse treatment systems persist.”201 Even with 
increasing numbers of practitioners trained in the treatment of co-
occurring disorders, structural barriers—including thousands of 
segregated drug and mental health courts—prevent individuals from 
receiving appropriate and integrated treatment. Better training for 
practitioners, standing alone, will not create lasting improvements in 
integrated treatment. As one author noted, “without structural, 
regulatory, and funding changes required to reinforce training, newly 
acquired expertise will not be used and will soon disappear.”202 
The existing research overwhelmingly supports the propriety and 
efficacy of integrated treatment for co-occurring mental health and 
substance use disorders.203 Yet our current national system of 
segregated and fractured treatment of individuals with co-occurring 
disorders makes it more difficult for individuals to obtain appropriate 
 
the underprivileged are terminated more frequently from drug courts, even perhaps in 
circumstances where they are doing just as well (or as badly) as their white and affluent 
counterparts.”); John R. Gallagher, African American Participants’ Views on Racial 
Disparities in Drug Court Outcomes, 13 J. SOC. WORK PRAC. ADDICTIONS 143, 156 (2013) 
(finding that minority participants in one drug court reported feeling that “it was common 
in court for the audience and drug court staff to laugh” when African American 
participants were given sanctions). 
 199. Joan E. Zweben, Severely and Persistently Mentally Ill Substance Abusers: Clinical 
and Policy Issues, 32 J. PSYCHOACTIVE DRUGS 383, 384 (2000); see also Clark et al., supra 
note 125, at 7 (“Although mental health and substance abuse treatment systems have 
historically been separate, the mental health system has been providing and encouraging 
more training on substance use disorders, and addiction treatment providers are increasing 
their capacity to deal with clients who have mental disorders.”). 
 200. Zweben, supra note 199, at 384 (“More and more addiction treatment providers 
are developing the capability of dealing with a population that has thought disorders for 
periods of time.”). 
 201. Clark et al., supra note 125, at 7. 
 202. Id. (“Even when qualified and well-trained clinicians are available, however, 
evidence suggests that training alone is not sufficient to sustain changes in clinical practice 
that are needed to promote integrated care.”). 
 203. See supra Part IV. 
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treatment and reduces the efficacy of the treatment that individuals 
do receive. Our system of treatment must be integrated to improve 
accessibility and the quality of treatment for individuals with co-
occurring disorders. Similarly, “[s]creening and referral must become 
routine so that mental and substance use disorders receive equal 
treatment.”204 The integration of drug, alcohol, and mental health 
courts would improve the treatment received by individuals who are 
diverted into specialty courts and correspondingly increase courts’ 
ability to “reach people who have co-occurring mild to moderate 
mental and substance use disorders before their conditions become 
more severe.”205 
In an integrated treatment setting, individuals receive 
appropriate mental health and substance use treatment from a single 
clinician or clinical team.206 Specialty courts already embrace this 
team approach to treating individuals. In the specialty court model, 
the judge approaches each case as the leader of a team that includes 
prosecutors, probation officers, defense attorneys, and social 
workers.207 The team creates a treatment plan that the defendant must 
agree to. Defendants participate in a variety of treatments, but those 
treatments are focused differently in different specialty courts.208 For 
example, drug courts “handle an underlying drug problem 
contributing to criminal behavior .	.	.	.”209 In drug court, “the goal 
remains consistent—drug treatment for addicted drug offenders 
instead of incarceration and/or probation.”210 Similarly, alcohol and 
DWI courts “focus on changing the behavior of the alcohol-
dependent offender .	.	.	.”211 Mental health courts, in contrast, divert 
defendants into “judicially supervised, community-based 
 
 204. Clark et al., supra note 125, at 6. 
 205. Id. 
 206. Drake et al., A Review of Treatments, supra note 128, at 367. 
 207. Edgely, supra note 35, at 572 (“A judge supervises a multi-disciplinary team that 
determines the most appropriate interventions for the offender, who is required to report 
back to the court at periodic status hearings.”). The judge and court personnel typically 
meet to review cases prior to status hearings with defendants. The team often includes 
prosecutors and defense attorneys, probation officers, and service providers. STRONG ET 
AL., supra note 26, at 9. 
 208. Id. at 9. 
 209. Id. at 2. 
 210. Hora et al., supra note 37, at 453.  
 211. STRONG ET AL., supra note 26, at 2.  
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treatment”212 and have the stated goal of connecting participants to 
available community resources.213 
The integration of drug, alcohol, and mental health courts would 
allow courts to tailor treatment plans to address co-occurring 
disorders simultaneously, which would ideally include “case 
management, vocational rehabilitation services, family counseling, 
housing, and medications.”214 Although many segregated specialty 
courts provide some or all of these services, most do not provide them 
with the explicit goal of addressing both disorders concurrently, 
resulting in inadequate treatment for both disorders. Moreover, the 
integration of segregated specialty courts would provide more 
opportunities for specialty court judges and court personnel to be 
appropriately trained in the screening and appropriate treatment of 
individuals with co-occurring mental health and substance use 
disorders. 
The literature on co-occurring disorders makes it 
overwhelmingly clear that individuals with co-occurring disorders 
“frequently fall through the cracks between the mental health and 
substance abuse treatment systems, are shuttled between systems that 
can only treat one type of disorder, or receive simultaneous care from 
clinicians in segregated treatment systems that do not have the 
capacity to share information.”215 This results in lower rates of 
treatment and poor treatment outcomes. Specialty courts, individual 
judges, and policymakers can take part in addressing this challenge by 
considering the integration of mental health and drug courts, which 
will allow the specialty court model to better adapt to our current 
understanding about the appropriate and integrated treatment of co-
occurring mental health and substance use disorders. 
While the integration of drug and mental health courts would be 
one step toward addressing these structural barriers to the 
appropriate treatment for co-occurring disorders, courts cannot take 
 
 212. Id. 
 213. ALMQUIST & DODD, supra note 29, at 2 (describing a variety of goals for mental 
health courts, including goals “to improve public safety by reducing the recidivism rates of 
people with mental illnesses, to reduce corrections costs by providing alternatives to 
incarceration, and to improve the quality of life of people with mental illnesses by 
connecting them with treatment and preventing re-involvement in the criminal justice 
system”); see also, e.g., Mental Health Court Explained, COUNSELING WASH., 
https://www.counselingwashington.com/FAQS/Mental-Health-Court-Explained/ [https://perma.cc/
GS99-GTHS] (“[T]he goal is .	.	. improved access to public mental health treatment services 
.	.	.	.”). 
 214. Lana A. Vornik & E. Sherwood Brown, Management of Comorbid Bipolar 
Disorder and Substance Abuse, 67 J. CLINICAL PSYCHIATRY 24, 28 (2006). 
 215. Clark et al., supra note 125, at 66. 
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on this task alone. As noted above, there is a significant lack of cross-
training in both mental health and substance abuse fields, and 
educational and training programs must be improved to address the 
specific challenges posed by this population.216 But the current 
organizational model of segregated specialty courts only exacerbates 
the challenge of appropriately treating individuals with co-occurring 
disorders. This lack of coordinated treatment “results in high 
recidivism, poor retention, poor treatment outcomes, and increased 
burden, not only for persons in need of care but also for service 
delivery systems.”217 
Finally, it is important that legislators and other policymakers be 
informed about the prevalence and appropriate treatment of 
individuals with co-occurring mental health and substance use 
disorders. States and the federal government continue to allocate 
hundreds of millions of dollars annually to the establishment and 
support of specialty courts.218 A better understanding of the efficacy 
of integrated treatment for co-occurring disorders can help guide 
legislators and policymakers as they look for ways to make “scarce 
dollars do more for a population known for the high cost of its 
treatment .	.	.	.”219 
CONCLUSION 
Specialty courts claim to have created a revolution in criminal 
justice, and, indeed, these diversionary programs do represent an 
important improvement. But the existing specialty court model, 
where individuals are segregated into drug, alcohol, or mental health 
courts, is contrary to the literature on both the disease of addiction 
and the prevalence of co-occurring substance use and mental health 
disorders. Moreover, segregated specialty courts are yet another 
barrier to the widespread acceptance of addiction as a brain disease, 
one that should be evaluated and treated like any other mental health 
disorder. 
 
 216. Hawkins, supra note 172, at 217 (“A significant barrier to the provision of 
integrated services is a lack of cross-training in both mental health and substance abuse 
fields. Educational and training programs can begin to address this by offering courses on 
co-occurring disorders and by providing clinical opportunities to work with this 
population.”); see also supra Part IV. 
 217. Foster et al., supra note 156, at 240. 
 218. Due to the large number of drug and mental health courts and their geographical 
diversity, it is difficult to identify precisely how much funding is received by these 
individual courts. One recent study, however, found that drug courts spent approximately 
$515 million per year on treatment. BHATI ET AL., supra note 50, at xi–xii. 
 219. Clark et al., supra note 125, at 3. 
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Drug, alcohol, and mental health courts should be integrated, 
both in recognition that substance abuse is a mental illness and not a 
crime and because co-occurring disorders in specialty court 
participants should be expected and appropriately treated. Specialty 
court judges, staff, and policymakers should similarly become better 
educated about advances in the research and integrated treatment of 
co-occurring disorders. Perhaps most importantly, by providing 
integrated treatment to specialty court participants, courts and 
policymakers can dramatically improve treatment outcomes for 
individuals who are diverted out of the criminal justice system and 
into a specialty court. 
 
